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ABSTRACT 
 
Toxin-membrane interactions are poorly understood on the molecular level due to 
the inherent difficulty of crystallizing membrane protein complexes and the large size 
(>50 kDa) of most functional AB or MARTX protein toxins. Toxins can interact with 
membranes at three stages during intoxication: 1) receptor binding to the cell surface, 2) 
membrane translocation, and/or 3) intracellular membrane targeting. To understand the 
intoxication process, it is necessary to develop an understanding of the structures, 
dynamics, and mechanisms through which toxins interact with membranes.    
In this thesis, we focus on the membrane-binding domains of Pasteurella multocida 
toxin, a 144-kDa dermonecrotic AB-type toxin that causes atrophic rhinitis, and 
homologous domains in other toxins. We address both the N-terminal domain 
necessary for receptor-mediated endocytosis into the cell, as well as the intracellular 
membrane localization domain (MLD), which is believed to be necessary to enable 
proper targeting of the catalytic domain for cytotoxicity.  
We demonstrate that the N-terminal receptor-binding domain preferentially binds to 
the membrane component sphingomyelin and a putative co-receptor (chapter 2), that 
the MLD undergoes a secondary-structure conformational change upon membrane 
interaction (chapter 3), and that this phenomenon has pH-dependent dynamics that may 
enable the MLD to survive the endosome before it becomes functional at cytosolic pH 
(chapter 4). This thesis provides a framework for understanding the topology and 
chemistry behind toxin-membrane interactions. 
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CHAPTER	  1	  
Introduction	  
1.1 Importance of Bacterial Protein Toxins in Pathogenesis 
One major area of exploration in the field of bacterial pathogenesis is the detailed 
mechanism by which a bacterium makes its niche suitable for both growth and 
sustainability. Pathogenic bacteria are defined as bacteria that invade hosts and cause 
an observable diseased state; these bacteria secrete a variety of factors that manipulate 
their host environment to assist in the bacterial survival.1 Human and agricultural health 
concerns lead us to focus on bacteria that live in mammalian hosts, and in particular on 
those specific biomolecules, which actively harm the host and result in a diseased state.  
Pathogenic bacteria utilize a variety of biomolecules called virulence factors to 
manipulate protective mechanisms of the mammalian host to sustain infection and/or 
cause the diseased state.2 The diseased state can often be attributed to and solely 
reproduced by introduction of a specific bacterial protein toxin; these toxins can cause 
dermonecrosis3, paralysis4, inflammation5, pneumonia3, and many other clinically 
observed diseased states. Toxins can act extracellularly, such as the superantigens that 
bind to major histocompatibility complexes and T-cell receptors to non-specifically 
activate the immune system and invoke strong systemic inflammatory responses5; 
directly on host cell membranes to disrupt cellular or vesicular membranes, such as the 
pore-forming toxins clostridial perfringolysin O (PFO)6 and VacA from Helicobacter 
pylori;7 or intracellularly, such as in the case of AB toxins, such as botulinum neurotoxin 
(BoNT), where an effector domain is delivered into the cytosol to cause paralysis by 
cleaving SNAP-25 to prevent vesicular fusion at nerve-muscle synapses.4  
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AB toxins mediate their effects on intracellular processes through multiple separate 
functional domains: the catalytic effector domain (A), which causes virulence, or the 
binding (B) domain, which is involved in binding to receptors on the mammalian cell 
surface, triggering uptake or internalization into the cell, and delivering the A domain to 
the host cell cytosol. Crystallization and biochemical functional analyses of the catalytic 
effector domains have significantly advanced the understanding of catalysis and 
subsequent disease caused by many of these AB toxins. However, much less is 
understood about the mechanism of delivery of the catalytic domain into the cytosol and 
the interactions of the binding domain with its cognate receptors and the cell membrane 
for the majority of bacterial toxins. 
1.2. Organization of Membranes and Membrane Components in Mammalian Cells 
The plasma membrane of mammalian cells contains a variety of biomolecules that 
help define the function of the cell, while also providing a chemical and physical barrier 
between the cell and its environment. This enables concentration and containment of 
essential molecules and nutrients, while also interacting through signaling molecules 
with the environment to ensure survival of the cell. The plasma membrane can perform 
this function due to its selective permeability; water and other small organic molecules 
can readily traverse the membrane, while transporter proteins can allow specific ions 
and small molecules into and out of the cell. The generic composition of the plasma 
membrane is 50% proteins, 40% lipids and derivatives, and 10% cholesterol and is 
discussed in greater detail below.8  
Membrane-associated proteins have a diverse range of functions. These proteins 
can serve as signal receptors, transporters of small molecules, mediators of cell 
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adhesion, and enzymes that catalyze various reactions, among many other functions. 
Proteins can be incorporated into the membrane in a variety of ways, depending on 
their function. For example, transmembrane proteins are often transporters or cell 
signaling transducers, while GPI-anchored proteins or surface associated proteins are 
involved in cellular adhesion and/or catalysis.9 
The lipid portion of the membrane is organized to support membrane structural 
integrity as well as protein function and organization. Cholesterol (CHL) helps ensure 
proper membrane fluidity and is characteristic of mammalian cells, while ergosterol and 
phytosterol provide the same function in fungi and in plants, respectively. Other major 
components are asymmetrically distributed between the extracellular and intracellular 
leaflet. The extracellular membrane is primarily a mixture of phosphatidylcholine (PC, 
~45% by molar composition), sphingomyelin (SM, ~40%) and 
phosphatidylethanolamine (PE, ~10%), with glycolipids, including ceramides (~2.5%), 
and ceramide-derived molecules such as gangliosides, comprising the rest (~5%).8,10-18 
This composition forms a surface that has a neutral overall charge with a high 
abundance of exposed phosphocholine head-groups. The membrane is further 
organized by the formation of detergent resistant membranes characterized by SM-
enriched regions that also contain elevated levels of CHL. 
Uptake of large biomolecules often occurs through receptor-mediated endocytosis.19 
Endosomes have a very similar composition to the plasma membrane in the early 
stages. However, as the endosomal trafficking progresses, proton pumps acidify the 
endosome until it 1) is merged with a lysosome to form a phagolysosome, 2) is re-
directed to the Golgi (such as during retrograde transport), or 3) is recycled back to the 
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cell surface. In the first case, acidification of the vesicle causes transition of the vesicle 
(pH 7.4) to an early endosome (pH 6.3) and then to a late endosome (pH 6.0), which 
finally merges with a lysosome to form a phagolysosome (pH 5.5).120 This acidification 
process occurs with a concurrent change in the phospholipid bilayer as the vesicles 
become enriched with the anionic lysophospholipid bis-monoacyl phosphate (~15%), 
while depleted in SM (~10%) in the late endosome, thus giving the vesicles an 
increasingly negative charge.8,20  
The inner leaflet of the plasma membrane, on the other hand, is rich with anionic 
phospholipids. The generic composition of the inner leaflet is comprised of PC (~25%), 
PE (~45%) and SM (~7.5%) and over 20% anionic phospholipids, including ~15% 
phosphatidylserine (PS), ~5% phosphatidylinositol (PI), and ~2.5% ceramides and 
ceramide-derived molecules.8,10-18 In response to certain cellular events, such as 
apoptosis, enzymes called flipases21 can cause phospholipid components of the inner 
leaflet to transfer to the extracellular surface22 and vice-versa. This generates 
opportunities for unique chemistries and binding events to trigger cellular processes, 
such as blood clotting,23 or to act as targets and/or receptors for proteins that localize to 
either extracellular or intracellular membranes.24  
1.3. Overview of Toxin-Membrane Interactions for Intracellular Bacterial Toxins 
AB toxins utilize the framework discussed above (chapter 1.2) to target specific cell-
lines based on their plasma membrane composition and thus the receptors on their 
surface,25,26 as a wide-range of protein and lipid receptors are known to be specific 
receptors for toxins, as discussed in greater detail in chapter 2. Upon endocytosis, 
toxins can manipulate endosomal trafficking27,28 to optimize translocation of effector 
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domains into the cytosol. Upon delivery of toxin effector domains into the cytosol, many 
targets are found near the membrane as discussed in chapter 1.5. Some studies have 
been focused on understanding the affinity and selectivity of toxins for their cognate 
receptors, but there are few atomic resolution structures of toxins interacting with 
membranes and/or receptors during any phase of the intoxication process. We believe 
understanding these toxin-membrane interactions to be imperative to understanding the 
intoxication process (Figure 1.1) and to manipulating it for toxin-based delivery of 
therapeutics. 
AB toxins are produced either as single-chain proteins, as in the case of DT or 
BoNT, or as individual subunits that assemble during or after secretion from the 
bacterial cell, as in the case of cholera toxin (CT, AB5) or Shiga toxin (ST, AB3), which 
form complexes in the bacterial periplasm, or anthrax toxin (AnTx, A3B7), which 
complexes on the host cell surface.29 The binding B domain of AB toxins is essential for 
binding to cell surface receptors and triggering cellular uptake of the cognate catalytic A 
domain. It is known, for example, that the light chain, containing the catalytic domain of 
BoNT is held to the heavy chain, containing the binding and translocation domains only 
by a disulfide bond; the disulfide bond becomes reduced upon exposure to endosomal 
conditions conducive to translocation.121 In the case of DT, the protease furin is believed 
to play a similar role in cleaving the catalytic domain from the translocation domain once 
DT is in the endosome.53 
Numerous AB toxins, including the toxins that will be the focus of this thesis, take 
advantage of toxin-glycan, toxin-lipid, and/or toxin-protein interactions to bind cells and 
trigger endocytosis. Gangliosides, which are often found in detergent resistant 
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membranes, are known receptors for BoNTs (disialoganglioside co-receptor)26,58-62, 
ST63 (globotriaosylceramide), and CT (monosialoganglioside).64 Other toxins bind to 
lipids; VacA binds to SM in detergent resistant membranes65, α-toxin binds to PC66, and 
PFO binds to CHL.67 In contrast, membrane-bound proteins have been identified as 
receptors for DT (heparin-binding EGF-like growth factor)68, cytotoxic necrotizing factor 
1 (CNF1, laminin receptor protein)69, and AnTx (capillary morphogenesis gene-2)70, and 
as a co-receptor for BoNT (synaptic vesicle protein 2, synaptotagmin).58,61,71,72 
Regardless of the receptor and the potential role it may play in promoting 
intoxication, binding of the toxin-binding domain to the appropriate receptor is necessary 
to facilitate endocytosis and intoxication.  
For multi-subunit AB toxins, such as CT34 and ST35, the AB subunit complex is taken 
up into the cell and trafficked through host-mediated retrograde transport to the Golgi 
apparatus. Upon arrival at the Golgi, the toxin uses the Sec61p translocon complex to 
facilitate translocation of the catalytic A subunit into the cytosol.24,28,29,32,33,36 We will not 
discuss multipartite AB toxins further as they are outside the scope of this thesis.  
For single-chain AB toxins, the catalytic activity A domain of are delivered across the 
cellular membrane and into the cytosol using one of two main mechanisms:   
 (1) Toxin-mediated membrane pore formation and effector domain translocation at 
the cell surface plasma membrane.37,38 Repeat-in-toxin (RTX) toxins bind to a receptor 
on the cell surface and mediate transport of their effector domains into the cytosol to 
confer toxicity. Upon receptor binding, some toxins such as the multi-functional auto-
processing repeat-in-toxin (MARTX) toxins produced by Vibrio species, form a pore on 
the cellular surface without further processing, although the exact mechanism is 
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unknown.37,38 It is believed that the repeat domains in the MARTX toxins, containing the 
motif (G-G-X-G-(N/D)-D-x-(L/I/F-X), are used to form a pore and cause translocation, as 
suggested by a potassium efflux assay.42-46 
(2) pH-dependent membrane pore formation that leads to toxin-mediated 
translocation of toxic effector domains across endosomal membranes. The more 
canonical single-chain AB toxins, such as DT39 and BoNT40, are endocytosed after 
binding to receptor. Acidification of the endosome triggers hydrophobic insertion of the 
translocation domain. For toxins such as botulinum neurotoxins (BoNTs) produced by 
Clostridium botulinum species and diphtheria toxin (DT) produced by Corynebacterium 
diphtheriae, it is believed that these pores form upon protonation of the side chains of D, 
or E residues present in a loop between two helices, which makes these residues more 
hydrophobic, favoring membrane insertion of this “dagger”. Upon exposure to the 
cytosol, the D and E residues become de-protonated, locking in the trans-membrane 
state.41,47-50 41	  It is hypothesized that protonation of Hs in the translocation of DT, 
particularly H223, H251, and H257, causes the tertiary structure to be destabilized, 
enabling insertion of the hydrophobic helices to generate a pore.51 Although the entire 
toxin is believed to exist in solution as a single polypeptide chain containing both the A 
and B domains, it has been hypothesized by some investigators that many single-chain 
toxins oligomerize once bound to the cellular surface and that this oligomerization is 
necessary for translocation.52 
A similar helix-loop-helix motif has been suggested in the related cytotoxic 
necrotoxizing factor 1 (CNF1) from E. coli49 and the dermonecrotic toxin from 
Pasteurella multocida (PMT).41 Mutagenesis of residues in the putative translocation 
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loop region of PMT (D401K, D425K, D431K, E434K, and E460K) significantly reduced 
or eliminated toxicity, presumably by preventing protonation in the endosome and 
thereby blocking pore formation in the late endosome that enables translocation of the 
catalytic domain into the cytosol.  
Upon pore formation the effector domain is delivered across the membrane into 
the cytosol. It is believed that either nonspecific proteases such as furin (for DT)53 or 
specific proteases (for MARTX toxins)45, and sometimes reduction of inter-domain 
disulfide bonds (for DT54 and BoNT)40, allow for separation of the functional catalytic 
domains from the binding and translocation domains. Additional chaperone proteins 
may be important in mediating the process (as for DT)55, but this mechanism is still 
poorly understood. Chaperone proteins do not appear necessary for DT translocation 
domains forming pores in vitro since even in the absence of chaperone proteins in 
synthetic bilayers, toxin-mediated leakage of high molecular weight dextrans has been 
observed upon acidification. This suggests that pore formation is thermodynamically 
favorable in the presence of liposomes alone.56,57  
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Figure 1.1: Diagram depicting the entry pathways of diphtheria toxin (DT) and 
VvMARTX toxin into the cytosol via membrane pore formation. Upon endocytosis of 
DT and acidification, the translocation domain forms a pore that the catalytic domain 
escapes into the cytosol through and targets the NAD(+)-diphthamide ADP-
ribosyltransferase, resulting in cellular intoxication (left). In VvMARTX (right), the 
MARTX repeats insert themselves into the membrane and form a pore to translocate 
the effector domains in the cytosol that are released by the cysteine protease domain 
(CPD). In other cases, retrograde transport to the trans-Golgi or progression to the 
lysosome occurs. 
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1.4. Membrane Interactions of Single-Chain Polypeptide Protein Toxins that 
Target the Inner Leaflet of Mammalian Cells 
 
Single-chain AB toxins and MARTX toxins utilize a domain-by-domain framework 
that can be viewed almost as a train with each compartment having a separate role and 
being connected by linker regions. The receptor-binding domain is normally found at 
either the N- or C-terminus, with the effector domains found at the opposite end, and the 
translocation domain is found in the middle (Figure 1.2). In the case of MARTX toxins, 
one of the effector domains is a cysteine protease domain (CPD). The CPD is a 
relatively non-specific protease that cleaves after L residues in loop regions between 
domains. The CPD is believed to generate a significant conformational change upon 
allosteric activation by the metabolite inositol hexakisphosphate (IP6), exposing the 
protease site, which enables cleavage of the linker regions and separation of the 
effector domains once within the mammalian cytosol.37,45 Release of the catalytic 
effector domains from the receptor-binding and translocation domains enables the 
effector domains to find their separate targets. It also enables the delivery of multiple 
combinations of effector domains, thereby increasing genetic and functional diversity 
while maximizing the effectiveness of intoxication. 
The question still remains as to how the effector domain finds its target substrate 
once it is inside the cytosol, as it is unknown whether finding its substrate solely based 
on diffusion or are there other factors that allow for effective and rapid targeting to the 
substrate. Effector domain targeting to anionic phospholipids in the inner leaflet of the 
plasma membrane has been shown for effector domains injected into the host cell 
through Type III74,122, IV30,75,76,123,124, and likely type VI secretion systems31,125. 
Membrane targeting effector domains has also been demonstrated in MARTX toxins 
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and several AB toxins, including PMT 84, as well as multiple toxins containing 
glucosyltransferases, including the clostridial toxins from Clostridium difficile TcdA, 
TcdB and from Clostridium sordellii TcsL.73 For this thesis, we will focus on translocation 
and membrane targeting of effector domains from MARTX toxins and the AB toxin PMT.  
 In the case of at least 24 bacterial protein toxins belonging to the classes of AB 
toxins or MARTX toxins, the effector domains are flanked at their N-terminus by a 
putative four-helical bundle (4HB) that delivers their respective effector domains to the 
 
 
Figure 1.2: Diagram depicting representative MLDs from AB and MARTX toxins. 
Sequences of 24 MLDs (top) with >25% sequence identity match.2 Top: 
Hydrophobic residues in yellow, charged residues in blue, and aromatic residues 
in green demonstrate regions of conserved or similar residues, especially around 
loop 1 (residues 10-20). Those MLDs that have been studied more extensively 
are in orange boxes and those that we have focused on in our studies are in red 
box. Bottom: A visual diagram of the domains of toxins containing functional 
MLDs and where these effector domains are found demonstrates the diversity in 
toxins that contain these conserved domains. 
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inner leaflet of the plasma membrane, where their target substrates are located (Figure 
1.2). These toxins have three general types of effector domains adjacent to the putative 
4HB: (1) glucosyl transferases (CGTs) including those at the N-terminus of the toxins 
from Clostridium difficile (TcdA and TcdB) and Clostridium sordelli lethal toxin (TcsL), 
(2) Rho-inactivation domains (RIDs) including those found in MARTX toxins from Vibrio 
cholerae (MLDVcRID) and Vibrio vulnificus (MLDVvRID), and (3) domains of unknown 
function (DUF) including the DUF5 of V. cholerae (MLDVcDUF5) and V. vulnificus 
(MLDVvDUF5)73,77 and the C2 domain of PMT.83. 
The function of the 4HB was unknown until work done by our collaborators, Brett 
Geissler and Karla Satchell at Northwestern University, determined that these 4HB 
specifically bound anionic phospholipids.73 Transfection studies using MLDVcRID-GFP 
and MLDVvDUF5-GFP revealed that the putative MLD next to the RID from the V. 
cholerae MARTX toxin targeted GFP to the host membrane. This was observed by co-
localization studies using fluorescence microscopy and a fluorescently labeled cellular 
marker consisting of the first 15 amino acids of tyrosine-protein kinase fused to mCherry 
dye that localizes to the membrane and the transfected MLD-GFP fusion proteins. This 
was also observed after cellular fractionation by western blotting using the antibody for 
GFP.77 A broader study was done using the liposome pulldown assay for a number of 
the MLDs, where the MLD from TcdB and TcsL were also shown to bind to anionic 
phospholipids, while that from V. vulnificus next to the RID domain (MLDVvRID) does 
not.73 
Mutational analysis was performed73,77 to determine if point mutations could restore 
membrane-binding activity of the inactive MLDVvRID. As expected for a domain that binds 
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negatively charged lipids, mutation of the positively charged K and R residues in loops 
L1 and L3 of the MLD significantly reduced binding. This suggests that electrostatic 
interactions in these loops are essential for proper membrane binding, which was 
supported by the dependence of MLD binding to synthetic liposomes on salt 
concentration.73  
It was hypothesized that hydrophobic insertion is important for membrane binding 
due to the observation that F, I, or other hydrophobic residues were favored at position 
16 in MLDs with strong membrane interactions (Figure 1.2). These putative hydrophobic 
insertions are believed to be important to stabilize the electrostatic binding of the MLD 
 
 
Figure 1.3: Initial model of MLD insertion into membrane lipid bilayer suggests 
that the anionic interactions in loops L1 and L3 (K12, K14, K18, R71) interact with 
the negatively charged anionic phospholipids on the inner leaflet (red), allowing 
for insertion of the hydrophobic F16 residue. Mutation to an N prevents 
hydrophobic insertion (right).73  
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to the membrane through hydrophobic insertion.73 This was supported by the mutation, 
N16F, where binding of MLDVvRID was increased by a factor of 6-fold and was further 
supported by a 6-fold decrease in binding observed for the reverse mutation F16N in 
MLDVvDUF5.  
While this was attributed to hydrophobic insertion of F16, TcdB has T16, which is not 
traditionally considered a hydrophobic anchor, yet still binds with similar apparent 
affinity to anionic membranes. Thus, it became apparent that atomic resolution 
structural and dynamics data would be necessary to fully understand the implications of 
these mutations and their role in membrane binding. We will discuss these studies in 
greater detail below in chapter 1.6.  
 
1.5. Mechanism of Intoxication by 
Pasteurella multocida Toxin, a Model 
Toxin for Understanding Membrane 
Interactions 
 
 To understand the many facets of 
toxin-membrane interactions, including 
the biophysical and structural 
characteristics of toxin-membrane 
interactions, I focused my study on PMT. 
PMT plays an important role in virulence, 
as infection with toxin-producing strains of 
Pasteurella multocida serotypes D or A or 
exposure to the toxin itself causes 
atrophic rhinitis primarily in swine, cattle, 
 
  
Figure 1.4:  Diagram depicting the 
structural and functional organization 
of PMT. (Top) A diagram depicting the 
structural organization of PMT. 
(Bottom) The crystal structure of the 
C-terminus of PMT containing the 
4HB in C1 (blue), the DUF5 in C2 
(gray), and the deamidase in C3 
(green). 
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sheep, and rabbits, as well as respiratory disease (pasteurellosis).119 Pasteurellosis is 
often observed as an upper respiratory disease that can cause a variety of diseased 
states depending on the serotype of the bacterium, including avian cholera in fowl. 
Atrophic rhinitis is an additional complication caused by PMT, which is characterized by 
the atrophy of the glands, bones, and nerve elements supplying the nose.78-80,119 
As shown schematically in Figure 1.4, PMT contains two putative functional regions: 
an N-terminal region that harbors the putative binding/translocation domain(s) (residues 
1-568), and a C-terminal region that harbors the intracellular activity domains (residues 
569-1285). The N-terminus of PMT is required for binding to cell surface receptors and 
mediates cellular uptake of the toxin through endocytosis, as evidenced by competition 
assays.81 This region also appears to contain the translocation domain based on 
sequence homology analysis and mutational analyses.27,41,82 The crystal structure of the 
C-terminal region (Figure 1.4) revealed three domains83: a C1 domain containing an 
MLD motif (569-670)	  84, a C2 domain containing a DUF with homology to DUF5 (671-
1103) of the Vibrio MARTX toxins, and a C3 domain containing a deamidase activity 
responsible for intracellular toxicity that constitutively activates G-proteins (1104-
1285).3,81,83  
Activation of these G-proteins causes a number of downstream signaling events to 
occur. In the case of Gq, this includes conversion of phosphatidylinositol 4,5-
bisphosphate (PIP2) to inositol trisphosphate (IP3) and diacylglycerol, stimulating 
calcium release from cells, and protein kinase C signaling, respectively.85-88 For other 
G-proteins, this causes downstream activation of the MAP Kinase Erk, RhoA activation 
by Rho guanine nucleotide exchange factors, as well as MAPK activation by PLCβ.89-94 
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The major observed effects of intoxication include mitogenesis and cytoskeletal 
rearrangements. Other phenotypes observed upon intoxication by PMT include: (1) 
Proliferative responses such as an increase in SRE-dependent gene expression, anti-
apoptotic factors, and tissue barrier permeability, and a decrease in tumor suppression; 
and (2) Inhibition of differentiation such as, a decrease in adipogenesis, cell 
differentiation, and osteogenesis.3 These studies led to development of luciferase-
based cell assays27,86 (NFAT-luciferase and SRE-luciferase) that respond to PMT-
mediated calcium mobilization and mitogenic signaling, respectively.  
While a number of studies have characterized the catalytic activity of PMT, the 
currently available knowledge about the structure and function of the membrane binding 
and translocation domains is much less complete (Figure 1.3). For the initial binding 
step, only a limited number of classical assays have been performed to identify the 
receptor for PMT.93,95 These previous studies have implicated gangliosides as the 
receptor for PMT. One study visualized gold-conjugated PMT entering cells after 
various treatment of either the toxin and/or the cells.95 Treatment with trypsin or other 
enzymes did not appear to inhibit endocytosis, but pre-incubation with gangliosdies 
did.95 A subsequent paper measured DNA synthesis to compare the effects on cells of 
treatment with PMT alone or after pre-incubation with gangliosides; this was done to try 
and verify that GM1 was the receptor of PMT,93 as well as to identify other potential 
receptors. Preliminary studies in the Wilson Laboratory showing the inability of PMT to 
bind GM1 using thin layer chromatography prompted a more intensive study to try and 
identify lipid and/or glycan receptors and became a goal of this thesis.   
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Upon endocytosis, intoxication of PMT has been shown to require the cellular 
GTPase Arf6, actin, and microtubules.27 Treatment with the actin polymerization 
inhibitor cytochalasin D and/or the microtubule inhibitor nocodazole prevented PMT-
mediated SRE-signaling activation. In addition, transfection and overexpression of the 
constitutively active Q67L, the constitutively cycling T157A, or the dominant-negative 
T44N Arf6 mutant reduced the activity by >30%. It has been shown that acidification to 
a pH of ~6 is necessary for translocation of the C-terminus of PMT across the 
endosomal membrane.27 It is believed that the N-terminus of PMT (PMT-N, residues 1-
568) mediates translocation via an undetermined mechanism, but likely via pore 
formation.  
The C-terminus of PMT (PMT-C, 569-1285) contains a deamidase domain that acts 
on α-subunits of specific G-proteins (Gq, Gi, G12, and G13) and causes constitutive 
activation of the affected G-proteins.96,97 Deamidation of these α-subunits was observed 
using differential mass spectrometry and was verified using isoelectric focusing 
experiments.98 SRE-luciferase assays in HEK-293 cells transfected with truncations of 
PMT-C revealed that the deamidase activity resides within the C3 domain.99 
Examination of the crystal structure revealed a key C1165-H1205-D1220 catalytic triad, 
which is supported by no observed deamidation of target G-proteins for the C1165S 
mutant.98 However, little was known about how PMT-C was directed to the membrane-
associated G-protein complexes. 
Recent studies have revealed a membrane targeting activity within the C1 domain of 
PMT-C.84 In this study, exogenous expression of PMT-C without or with the 4HB (671-
1285), followed by western blotting and fluorescence microscopy, showed membrane 
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localization occurs only with the full length PMT-C construct possessing the C1 domain. 
A loss in the potency of the transfected PMT fragment missing the 4HB was also 
observed, as measured by downstream signaling according to SRE-luciferase activity 
assays.84 The corresponding surface plasmon resonance (SPR) experiment measuring 
binding to synthetic liposomes without or with the 4HB indicated a strong preference for 
anionic phospholipids, when the 4HB was present. These experiments provided strong 
evidence that the likely role of the 4HB-containing MLD in PMT is to bind anionic 
phospholipids and thus target the effector domains to the inner membrane leaflet of the 
cell, where their cognate substrates are located. From these studies, it was evident that 
the MLDs bind indiscriminately to liposomes and/or membranes containing anionic 
phospholipids at pH 7.4, that they can be crystallized attached to their effector domains 
as a 4HB, and that they increase the potency of their respective effector domains.   
1.6. Experimental Methods and Techniques to Better Understand Toxin-
Membrane Interactions – Overall Approach 
 
While previous work identified receptors for various PMT domains, gaps remained in 
our understanding of the specificity and affinity of PMT for its receptors (Figure 1.5). 
Many of the biophysical assays performed to determine binding of PMT-N to its receptor 
are discussed in much greater detail in chapter 2, while studies on the structure and 
dynamics of the MLD binding to its receptor are discussed in chapter 3 and 4.  
Affinity-tag pulldown 
Determination of protein receptors can be done via pulldown assays100,101, but are 
limited to high-affinity receptors unless chemical cross-linking is used to stabilize the 
complex. Identification of the protein from these pulled-down complexes can be 
performed using N-terminal sequencing or mass-spectral analysis of tryptic peptides of 
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the pulled-down proteins and then verified through use of receptor-knockout cell lines to 
determine the effect on toxicity.102,103 Due to the scope of this thesis, we did not pursue 
this approach past initial receptor-binding studies and instead focused on exploring 
toxin-membrane interactions using other techniques. 
Thin-layer chromatography 
One method often used to identify ganglioside and lipid receptors is thin-layer 
chromatography (TLC). In short, lipids are spotted onto a TLC plate and the bottom of 
the plate is placed into an appropriate solvent system. This causes solvent to be drawn 
up and through the silica plate, causing the lipid components to separate based on 
polarity. The silica plate is dried and then blotted with radiolabeled toxin to identify 
protein bands that might correspond to lipid and/or ganglioside receptors. By using TLC, 
lipid mixtures and native membranes can also be studied and then compared to 
standards to identify whether its receptor exists in a particular cell line and if there is any 
preferential binding observed among membrane components. This has been done for 
both CT104 and ST105 to show that they bind their respective gangliosides, monosialyl 
ganglioside for CT and globotriaosylceramide for ST.  
Liposome Pulldown 
Liposome pulldown assays, where toxin is incubated with vesicles doped with the 
appropriate receptor, has also proven to be an effective way to verify receptor binding in 
the more native phospholipid bilayer and has been used successfully on the MLDs to 
elucidate their preference for anionic phospholipids.73 We used this technique to study 
both PMT-N and MLDPMT to verify the binding of these domains to a lipid receptor on the 
more physiologically relevant bilayer present in liposomes. 
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Surface Plasmon Resonance 
Surface plasmon resonance (SPR)106 and enzyme-linked immunosorbent assays65 
are effective methods to generate thermodynamic profiles of binding of toxin binding 
domains to membranes by varying toxin concentration. SPR can be used to determine 
relative kinetic on and off rates of toxin binding domains at a particular concentration to 
various membrane compositions; these membranes can be either be from synthetic 
lipids/liposomes or from cellular extracts. These membranes are captured by the L1 
chip and used as a SPR platform to determine toxin-membrane affinity. The L1 chip 
captures membranes because it contains both alkyl and carboxymethyl groups in a 
dextran matrix enabling the capture of vesicles containing phosphatidyl choline and 
incorporation into SPR.   
Structural Approaches: NMR – Solution and Micelle-Bound 
 
The above-mentioned biological assays provide insight into how PMT interacts with 
membranes and the available crystal structures of the C-terminus of PMT demonstrate 
one conformation of PMT in the soluble state. However, there is no direct molecular 
evidence of how PMT interacts with the membrane at the atomic level during each of 
the receptor-binding, translocation, and the membrane-targeting steps. While ongoing 
efforts to crystallize MLDPMT, PMT-N and/or full-length PMT would provide evidence 
regarding binding pockets or sites involved in membrane interactions, there is still no 
atomic resolution structure of any PMT receptor-binding or membrane-binding domain 
alone in solution or in its active membrane-bound state or in the presence of any 
membrane mimetic.  
 
	   	   	   	   	   	  21	  
 
  
 
Figure 1.5: Proposed intoxication pathway of PMT highlighting toxin-membrane 
interactions. The proposed mechanism of toxin binding and delivery (right) shows 
the three times toxin-membrane interactions are believed to occur (endocytosis, 
translocation, and membrane targeting) as well as the opportunity to study these 
interactions in greater detail, as marked by question marks. 
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X-ray crystallography is problematic for solving structures of membrane proteins 
since membrane-protein complexes are notoriously difficult to crystallize.107 There are 
no crystal structures of AB toxins or MARTX toxin domains embedded within 
physiologically relevant bilayers, and few that are embedded within detergents. 
Structures of membrane-bound toxins are currently limited to those that capture the 
pore-forming state of oligomeric toxins from the cholesterol-dependent cytolysin family, 
which are not AB toxins related to PMT or MARTX toxins.108-111  
It should be noted that Cryo-EM has been used to make electron density maps that 
model translocation domains in the presence of membranes or at low pH, but has been 
used only for anthrax toxin thus far.112 Cryo-EM also requires a crystal structure of the 
protein being studied in order to properly model the translocation state. Models 
generated from Cryo-EM data tend to lack the detailed chemical information that will 
enable full understanding of the mechanism, thermodynamics, and dynamics that drive 
membrane binding and potential insertion.112 In addition, the cryo-EM map fitting 
assumes no significant changes in secondary structure and only provides indirect 
evidence of tertiary conformation changes.  
In this thesis, we use NMR approaches to improve our understanding of toxin-
membrane interactions at the atomic level. NMR provides a unique platform from which 
to interrogate and eventually solve atomic resolution structures and to determine the 
dynamics of the free toxin in solution and toxin-membrane interactions. Technical 
challenges arise for larger proteins in NMR that make studies using the smaller MLDs 
ideal as we venture into understanding toxin-membrane interactions.113 Primarily, as the 
size of the complex increases, the rate of tumbling decreases. This results in a 
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broadening of the observed linewidth as dipolar couplings become re-introduced, also 
resulting in a reduction of signal-to-noise ratio (SNR).  
While use of solid-state NMR (SSNMR) or solution NMR using TROSY pulse 
sequences are potential answers to this problem, spectral complexity still makes 
complete assignment as well as solving the structure for domains larger than 50 kDa 
using solution NMR impractical in many cases.114 For SSNMR, assignments have only 
recently been shown to be possible for membrane protein complexes of up to ~40 kDa 
by SSNMR.115,116 It is easier to study large complexes using SSNMR since solution 
NMR relies upon the tumbling rate to eliminate dipolar couplings, which is dependent on 
size, while SSNMR utilizes the magic angle between the magnetic field and the rotor to 
eliminate dipolar couplings, which is by definition size independent.117  
In order to reduce complex size for solution NMR, micelles are often used as a 
membrane mimetic that can be used in solution NMR to assign and solve protein-
membrane complexes. Use of micelles can enable assignment of the protein-micelle 
complex without deuteration for proteins up to ~15 kDa.118 In the case of toxin effector 
domains, it has been shown that the MLD, which is ~10 kDa, is both necessary and 
sufficient to bind to anionic phospholipids, and membrane-localization can be observed 
by swapping out its effector domain with a reporter protein, such as GFP.73,77 Thus, we 
have narrowed our focus to the MLDs for NMR studies in this thesis.   
The work performed in this thesis demonstrates significant advances in knowledge 
for toxin-membrane interactions. This work includes studies ranging from the 
fundamental biological characterization of receptor binding for PMT-N, as well as the 
state-of-the-art membrane-toxin structural studies, primarily using solution NMR to 
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enhance our knowledge of toxin-membrane interactions for the MLDPMT and the 
homologous MLDVvDUF5.  
Chapter 2 describes our published work that demonstrates PMT binds to SM and 
possibly a protein co-receptor in membranes. Chapter 3 is comprised of two published 
assignment notes as well as details with regards to sample preparation. Our studies of 
the solution and micelle-bound states of MLDPMT and MLDVvDUF5 and for the SSNMR 
assignments for MLDVvDUF5 in the liposome-bound state demonstrate that the MLD is a 
structurally stable domain, which undergoes secondary structural changes upon binding 
to the membrane. Chapter 4 explores the dynamics associated with pH and the effect 
this has on membrane binding and discusses physiological implications, as well as 
future directions. Chapter 5 addresses the broader implications this work has for the 
structural biology and bacterial pathogenesis communities.  
In summary, working with our collaborators and colleagues, significant progress has 
been made to understand the biophysical nature of the initial binding events of PMT 
with its cellular receptors and the subsequent intracellular membrane targeting events 
mediated by the MLD of PMT and homologous MLDs in MARTX toxins with model 
membranes. Results from these studies enhance our knowledge of the intoxication 
process, while providing insight into unique structures and dynamics for membrane-
associated proteins and domains.  
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CHAPTER 2 
Membrane Interaction of Pasteurella multocida Toxin Involves 
Sphingomyelin 
2.1. Notes and Acknowledgments 
This chapter is adapted with kind permission from the Federation of European 
Biochemical Societies Journal article, entitled "Membrane interaction of Pasteurella 
multocida toxin involves sphingomyelin", year 2011, volume 278, pages 4633-48, 
authors: Michael C. Brothers, Mengfei Ho, Ram Maharjan, Nathon C Clemons, Yuka 
Bannai, Mark A. Waites, Melinda J. Faulkner, Theresa B. Kulenschmidt, Mark S. 
Kuhlenschmidt, Steven R. Blanke, Chad M. Rienstra, and Brenda A. Wilson. This work 
was supported by NIH/NIAID grant AI038396 (to B.A.W), NIH/GM GM075937 (to 
C.M.R.), and the NIH/CBI Training Grant and DHS graduate fellowship (to M.C.B.). We 
thank Liping Wang for technical assistance with the Biacore facilities. 
2.2. Summary  
Pasteurella multocida toxin (PMT) is an AB toxin that causes pleiotropic effects in 
mammalian host cells. The N-terminus of PMT (PMT-N) is believed to harbor the 
receptor-binding and membrane-translocation domains responsible for mediating 
cellular entry and delivery of the C-terminal catalytic domain (PMT-C) into the host 
cytosol. Previous studies have implicated gangliosides as the host receptors for PMT 
binding. To gain further insight into the interactions involved in PMT binding to cell 
membranes, we explored the role of various membrane components in PMT binding, 
utilizing three different approaches: TLC-overlay binding experiments with 125I-labeled 
PMT, PMT-N or PMT-C; pulldown experiments using reconstituted membrane 
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liposomes with PMT-N, and surface plasmon resonance (SPR) analysis of PMT-N 
binding to reconstituted membrane liposomes and HEK-293T cell membranes without 
or with sphingomyelinase, phospholipase D, or trypsin treatment. Results revealed that, 
in our experimental system, PMT did not bind to gangliosides, including GM1, GM2 or 
GM3, but instead bound to membrane phospholipids, primarily phosphatidylcholine 
(PC), phosphatidylethanolamine (PE) and the most abundant sphingophospholipid 
sphingomyelin (SM), with the highest affinity binding observed for SM. Collectively, 
these studies demonstrate the importance of SM for PMT binding to membranes.  
2.3. Introduction  
PMT is a 1,285-amino acid AB toxin that is both a potent virulence factor associated 
with atrophic rhinitis and pasteurellosis1 and a tool for understanding G-protein 
signaling.2,3 PMT is one of the most potent known mitogens and triggers mitosis in 
fibroblastic and osteoblastic cells4-6 by activating heterotrimeric G proteins of the Gq, 
G12/13, and Gi families through deamidation of a critical active site glutamine residue.7-11 
As a consequence, PMT interferes with numerous cellular processes in targeted host 
cells. 
The crystal structure of PMT-C (residues 575-1285) has been elucidated12 and 
consists of three domains, C1-C3, where C1 is the intracellular membrane-targeting 
domain containing the MLD13, C2 is a domain of unknown function, and C3 is the 
minimal functional catalytic domain containing the active site C1165-H1205-D1220 
catalytic triad responsible for deamidation of the target G protein substrates.14 PMT-N is 
believed to consist of the receptor-binding domain and contains a putative membrane 
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insertion motif (residues 370-470) believed to be involved in membrane translocation of 
PMT-C into the cytosol.15,16 
PMT-N shares significant sequence similarity with the N-terminal regions of the 
cytotoxic necrotizing factors of E. coli (CNF1, CNF2, and CNF3)17-19 and Yersinia 
pseudotuberculosis (CNFY).20 These shared regions are believed to be important for 
toxin binding and translocation.15,16,21-24 There is evidence for the involvement of the p37 
laminin receptor precursor (LRP) in CNF1 binding to host cells21-23 and heparin sulfate 
proteoglycan (HSPG) in both CNF1 and CNFY binding to cells.21 It has been suggested 
that gangliosides play an important role in PMT binding25,26, and there is no current 
experimental evidence for the necessity of a protein-binding partner for PMT.  
AB toxins are known to employ various forms of receptors to gain entrance into cells, 
including gangliosides alone as for cholera toxin (CT)27, proteins alone as for diphtheria 
toxin (DT)28, or both proteins and gangliosides as for the tetanus neurotoxin (TeNT) and 
botulinum neurotoxins (BoNTs).29,30 This raises the question as to whether binding 
gangliosides alone is sufficient for cellular entry of PMT, or gangliosides in conjunction 
with other cellular protein components might also be required for productive docking 
and endocytosis.  
We used thin layer chromatography (TLC) overlay, liposome binding, and surface 
plasmon resonance (SPR) methods to further characterize the nature of the membrane-
binding partners of PMT and to study the interaction properties of PMT on reconstituted 
membranes or membrane ghosts generated from lysed HEK-293T cells. We found that 
contrary to previous reports PMT did not bind sialogangliosides on TLC plates. Instead, 
PMT showed affinity for several less polar membrane lipid components and positively 
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Figure 2.1: Binding of PMT to cellular membrane components. (A) Total cell 
membrane extracts (50 nmol phosphate equivalent) developed in the TLC solvent 
system of 75:25:4 (see Materials and methods). (B) Purified cell membrane 
components (10 nmol phosphate equivalent) developed in the TLC solvent system of 
75:25:4. (C) Purified gangliosides and porcine ganglioside mixture (PGM, 20 µg) 
developed in the TLC solvent system of 25:20:3. Right panels show images of 
overlays with the indicated radiolabeled proteins recorded by phosphorimager. Left 
panels show images of the corresponding TLC plates subsequently stained with 
CuSO4. Experiments performed by Mengfei Ho and Ram Maharjan. 
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charged phospholipids. PMT also showed enhanced binding for phosphatidylcholine 
(PC) liposomes containing sphingomyelin (SM). Removal of the SM headgroup from 
lipid ghosts of HEK-293T cells through treatment with Bacillus cereus sphingomyelinase 
(SMase) caused the most drastic changes in PMT-dependent SPR sensorgrams, while 
treatment of the lipid ghosts with phospholipase D (PLD) to remove the choline 
headgroup or trypsin resulted in reduction of PMT binding. Our results implicate 
interplay among SM and PC membrane lipid components, as well as unidentified 
proteins in the binding of PMT to cells. 
2.4. Results  
Binding of PMT to lipid extract components from mammalian cells. TLC in 
combination with overlaying labeled proteins is a valid method for determining protein-
ligand interactions and has been used extensively for confirming protein toxin utilization 
of gangliosides and/or phospholipids as receptors for gaining entry into target cells, 
including cholera toxin31, shiga-like toxins32-34, Bacillus thuringiensis crystal toxin35, and 
TeNT and BoNTs.36-39 To test whether PMT can directly bind to membrane lipid 
components, we employed an overlay technique in which purified lipids or crude lipid 
extracts from PMT-susceptible Vero, HEK-293T and NG108-15 cells were resolved on 
TLC plates using appropriate solvent systems. 
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 After blocking with bovine albumin serum (BSA), plates were overlayed for 1h with 
125I-rPMT in phosphate buffered saline (PBS), pH 7.4, at 37oC. After washing away 
unbound toxin, 125I-rPMT bound to lipids was detected using a phosphorimager (Fuji 
FLA-3000). We found that 125I-rPMT was able to bind to a number of lipid components, 
with the three major binding components present in all three cell lines assigned as A, B, 
and C (Figure 2.1A, 2.1B). However, there was an absence of 125I-rPMT binding to 
certain other lipid components, such as A1 and D, on the same TLC plate.  
	  
Figure 2.2: Binding of PMT and PMT fragments to phospholipids. Images of TLC 
plates loaded with cell membrane lipids (50 nmol phosphate equivalent) and purified 
phospholipids (10 nmol phosphate equivalent each), PC, PE, PI, PS and SM, and 
developed in the TLC solvent system of 75:25:4 (see Materials and Methods). Right 
panels show images of overlays with the indicated radiolabeled proteins recorded by 
phosphorimager. Left panels show images of the corresponding TLC plates 
subsequently stained with CuSO4.  Experiments performed by Mengfei Ho and Ram 
Maharjan. 	  
	   	   	   	   	   	  42	  
PMT does not bind GM1, GM2, GM3 or mixtures of porcine gangliosides (PGM) on 
TLC plates. Although previous reports suggested a role of gangliosides, namely GM1, 
GM2, and GM3, in cellular uptake of PMT25,26, 125I-rPMT did not bind these three mono-
sialogangliosides or other di- or tri-sialogangliosides deposited on TLC plates at 37°C 
(Figure 2.1C). Although prolonged exposure of 125I-rPMT at low temperature (16 hr, 
4°C) showed 125I-rPMT binding to GM3, the asialoganglioside, lactosylceramide 
(LacCer), bound 125I-rPMT much more efficiently, even at 37°C.  
PMT binds positively charged phospholipid and sphingophospholipid 
headgroups. Among the major phospholipids found in cell membranes, PE, PC, PS, 
and PI, and the abundant sphingophospholipid SM, the most efficient binding of 125I-
rPMT was observed for PC and SM, while PE and PI showed only weak binding, and 
PS showed no detectable binding (Figure 2.2). Studies using 125I-PMT-N and 125I-PMT-
C revealed that the N terminus contributed to the strong binding observed for full-length 
125I-rPMT to PC and SM and the weaker binding to PE, while the C terminus contributed 
	  
Figure 2.3: Relative affinity of PMT binding to phospholipids and lactosylceramide. 
Images of TLC plates loaded with incremental amounts of LacCer and developed in 
the TLC solvent system of 85:15:1 (see Materials and methods) or with PE, PC and 
SM and developed in the TLC solvent system of 75:25:4. Right panels show images 
of overlays with the indicated radiolabeled proteins recorded by phosphorimager. 
Left panels show images of the corresponding TLC plates subsequently stained with 
CuSO4. Experiments performed by Mengfei Ho and Ram Maharjan. 
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only partially to the binding of PC and SM and was primarily responsible for the weak 
binding to PI (Figure 2.2). Semi-quantitative analysis of 125I-rPMT binding to the three 
positively charged phospholipid headgroups clearly showed a binding preference of SM 
> PC >> PE (Figure 2.3). The asialoganglioside, lactosylceramide (LacCer), was also 
found to bind 125I-rPMT in a manner comparable to that of PC but less than SM (Figure 
2.3).  
PMT-C uniquely binds highly polar gangliosides. Although full-length 125I-rPMT and 
125I-PMT-N showed no affinity for sialogangliosides, 125I-PMT-C surprisingly showed 
affinity for GM1 and more polar di- and trisialogangliosides in mixtures of porcine brain 
gangliosides (Figure 2.4). This suggests that the binding characteristics of 125I-PMT-C 
are different than those of the full-length toxin. 
Other lipid components showed affinity for PMT on TLC. It was noted that full-
length 125I-rPMT bound the relatively more polar components in cellular lipid extracts. 
Further TLC overlay analysis showed that 125I-rPMT also bound to cholesterol, stearic 
acid, and mono- and di-glycerides. In addition to LacCer, 125I-rPMT also bound other 
asialogangliosides, including galactosylceramide (GalC), glucosylceramide (GlcC), 
ceramide I (CerI), and ceramide II (CerII). However, with these less polar lipid 
compounds, binding that was specific to the N terminus or C terminus of PMT was not 
apparent.  
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PMT has high affinity for sphingomyelin. The importance of SM in PMT binding to 
membranes was further studied using liposomes containing a mixture of 10% 
cholesterol and 90% lipid, comprised of either PC only or PC/SM, PC/PE or PC/PS at a 
ratio of 3 to 1. At an rPMT concentration of 10 µg/mL (or 68 nM), 1 mg of PC/SM 
	  
Figure 2.4: Binding of PMT and PMT fragments to gangliosides. Shown are 
representative images of TLC plates: (lanes 1–3) cell membrane lipid extracts as 
indicated (50 nmol phosphate equivalent); (lane 4) a ganglioside mixture (20 µg) 
containing mostly GM1, GD1a, GD1b, GT1b and lesser amounts of GM2 and GM3; 
(lane 5) purified GM1 (10 µg); and (lane 6) purified GM3 (10 µg). The labeled band in 
the three lanes for cellular membrane lipids corresponds to the lipid component B 
(PC). Only PMT-C bound GM1 and other more polar gangliosides. All TLC plates were 
developed in the TLC solvent system of 25:20:3 (see Materials and Methods). Right 
panels show images of overlays with the indicated radiolabeled proteins recorded by 
phosphorimager. Left panels show images of the corresponding TLC plates 
subsequently stained with CuSO4. Experiments performed by Mengfei Ho and Ram 
Maharjan. 
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liposomes captured ~4% of PMT from the solution, while PC only or PC/PE or PC/PS 
liposomes captured rPMT to a lesser extent (~1.5%) (Figure 2.5A). This same 
phenomenon is seen at a ratio of 1 to 1, except that increased binding was observed for 
PC/PS. Binding of PMT to GM1 or LacC in PC enhanced binding, but in the presence of 
25% SM did not enhance binding (Figure 2.5C).  This suggests that what is more 
important is breaking up PC or SM into domains is more important than the composition 
of the phosphocholine rich liposomes for equilibrium binding.  
Analysis of PMT-N interaction with reconstituted phospholipid membranes by 
surface plasmon resonance. SPR studies have been used to characterize binding 
interactions of ligands with gangliosides and protein binding partners. SPR sensorgrams 
of PMT-N binding to the three reconstituted membranes (PC only, PC/PS, or PC/SM) on 
a Biacore L1 chip (carboxymethyl dextran matrix with additional hydrophobic alkane 
groups) clearly showed a rapid and a slow component to both the binding and 
dissociation events (Figure 2.6A). PC/SM showed the highest resonance unit (RU) at 
high PMT-N concentrations and appeared to be far from saturation even at 7.5 µM 
PMT-N, suggesting a greater loading capacity for PC/SM membranes (compare Figure 
2.6B, 2.6C and 2.6D). PC/PS appeared to be near saturation at 7.5 µM PMT-N, 
suggesting that PC/PS membranes contained the fewest number of binding sites 
among the three membranes (Figure 2.6C). The sensorgrams were further analyzed 
using a bi-phasic exponential binding model (Equations 1-3) coupled with a bi-phasic 
exponential dissociation model (Equations 4), as defined in the experimental section.   
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Figure 2.5: Binding of rPMT to liposomes. (A) Shown are representative images 
from more than three independent repeats of Coomassie Blue-stained 10% SDS ⁄ 
PAGE analyses of pellets from pulldown experiments using the indicated 
liposomes, as described in the Materials and methods. The control (CTL) was 
from the pellets of a mock treatment of PMT solution without liposomes. (B) 
Quantitative analysis of the amount of rPMT bound to the indicated liposome 
preparations from three independent repeats of pulldown experiments similar to 
that in (A), as described in the Materials and Methods.	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 The best fit kinetic parameters, using a least squares method according to this 
model, were used to construct a theoretical resonance signal for the total resonance 
signals, consisting of the rapid and slow component resonance signals of PMT-N 
binding. There was a general agreement between the calculated curves and the 
corresponding experimental sensorgrams. The calculated parameters showed highest 
binding capacity (Bmax) in PC/SM membranes for both rapid and slow components 
(Table 2.1). Although the dissociation rates (koff) were similar among the three types of 
membranes, PC/SM appeared to have a lower association rate (kon) for the slow 
components. Both the slower association rate (kon) and the higher Bmax calculated for 
PC/SM membranes were consistent with the sensorgrams, indicating that PC/SM 
membranes were farther away from saturation than the other two types of membranes 
at high concentrations of PMT-N. For all three reconstituted membranes, rapid binding 
was detected at concentrations as low as 7.5 nM, but slow binding became prominent 
only at concentrations of 750 nM or higher. 
Analysis of interaction between PMT-N and HEK-293T cell membranes by SPR. 
SPR is a well-established method for studying the kinetic and thermodynamic 
interactions of toxins with their ganglioside40,41 and/or protein receptors42, including 
Shiga-like toxins40, E. coli heat-labile toxin43, CT41,43, anthrax toxin42, TeNT43 and 
BoNTs.44 Kinetic analysis of SPR data has been established using a Langmuir binding-
dissociation model, as described by O’Shannessy et al.45 In practice, most binding 
sensorgrams appear to show a biphasic behavior. The portion of the sensorgram 
showing rapid change is often attributed to a “bulk shift” or other nonspecific 
phenomenon and is generally ignored for calculations. However, our methodology does 
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not ignore this phase and thus requires parsing of the curve into multiple phases. There 
have been attempts to analyze the dissociation curve as two distinct phases41 or to treat 
it as a transitional behavior during binding.44 For simplification, we treated the biphasic 
behavior as a sum of two separate events, a rapid binding component and a slow tight 
binding component. We found our approach fitted well across a wide range of analyte 
concentrations in both the association phase and the dissociation phase. Our model 
does not exclude the possibility that the rapid binding event will transition into the slower 
tight binding event, i.e., a conformational transition model. 
 
Liposomes prepared from membrane ghosts of HEK-293T cells were loaded onto an 
Biacore L-1 chip. SPR sensorgrams of PMT-N bound to these natural membrane 
liposomes showed concentration-dependent binding, with prominent binding observed 
Table 2.1: PMT-membrane binding characteristics on various reconstituted membranes 
or natural membranes determined by SPR analysis. The untreated and enzyme-treated 
natural membranes are designated as Native, Trypsin, SMase, PLCCab or PLCSc. T 
indicates additional trypsin treatment after lipase treatment. The number of repeats N is 
the repeat of a set consisting of four recording signals from four flow channels of the 
same L1 chip.  
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at concentrations higher than 750 nM (Figure 2.7A), which was five times higher than 
that observed with reconstituted phospholipid membranes (Figure 2.6). After fitting the 
sensorgrams to a two-component model, the contribution of the calculated rapid binding 
component to the overall SPR signal for natural membranes was less than that for 
phospholipid membranes. Even so, the sensorgrams for PMT-N binding to natural 
membranes did not fit well using a single step binding-dissociation model.  
 
	  
Figure 2.6: SPR traces of PMT binding to liposomes. Example of traces generated 
using SPR from reconstituted lipids. Membrane vesicles were generated and loaded 
onto an L1 chip, as described in the Materials and methods. (A) Shown is an SPR 
trace for PC vesicles with initial injection of 3.75 µM BSA (labeled ‘B’) followed by 
dissociation (indicated by downward arrows) and injections of PMT (labeled 1–5) at 
concentrations of 7.5 nM, 75 nM, 750 nM, 3.75 µM and 7.5 µM punctuated with 
dissociation events. Also shown are example traces from all four channels of the L1 
chip preloaded with (B) PC, (C) PC⁄PS or (D) PC⁄SM vesicles, followed by five serial 
PMT-N injection–dissociation events, similar to the sequence shown in (A). 
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Effect of sphingomyelinase treatment on PMT-N binding to HEK-293T cell 
membranes. SMase cleaves the phosphocholine headgroup from SM and forms 
ceramide-rich domains in membranes that can lead to hemolysis of erythrocytes.46 
Liposome binding and TLC overlay indicated that PMT interacts with SM (Figures 2.2 
and 2.5), and reconstituted phospholipid membranes containing SM showed higher 
capacity for binding PMT-N when analyzed by SPR. To explore the importance of the 
headgroup in PMT-N interactions with membranes, HEK-293T cell membranes loaded 
on Biacore L-1 chip were treated with SMase. The results showed a noticeable 
decrease in the slow and tight binding; however, the rapid and loose binding increased 
by 10-fold (compare Figure 2.7C vs. 2.7A, Table 2.1). The KD of PMT-N for SMase-
treated membranes also increased by 3- and 2-fold for the rapid and slow binding 
components, respectively. The changes in kinetic parameters upon SMase treatment 
were consistent with decreased PMT-N binding to membranes due to removal of the 
phosphocholine headgroup by SMase, suggesting the importance of the headgroup for 
binding interactions.  
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Table 2.2: Potential cellular receptors for PMT screened by the TLC-overlay 
method. A qualitative score was given for lipids that always bound well (+, ++ or 
+++), that bound weakly or not always bound (+ ⁄ -)) or that never bound (-)). 
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Figure 2.7: SPR traces of PMT binding to cell membranes and enzyme-treated cell 
membranes. Shown are representative sets of traces recorded from all four channels of 
the L1 chip, preloaded with (A) native membranes, or membranes treated with (B) 
trypsin, (C) SMase, (D) SMase and trypsin, (E) PLDCab, (F) PLDCab and trypsin, or 
(G) PLDSc. Four graphs shown in each row are the recorded traces (Exp.), the 
calculated curves (Calc. Total), the calculated curve for the rapid components (Calc. 
Rapid) and the calculated curves for the slow components (Calculated Slow), 
generated as described in the Materials and methods. For the native membranes, 
PMT-N at concentrations of 75 nM, 750 nM, 3.75 µM or 7.5 µM were used (four 
binding-dissociation events). For all other membranes, an additional concentration of 
15 µM was used (five binding-association events). 
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Effect of phospholipase D treatment on PMT-N binding to HEK-293T cell 
membranes. PLD cleaves off the headgroups of phospholipids and forms phosphatidic 
acid. PLD from Streptomyces chromofuscus (PLDSc) has a substrate specificity for 
PC>PE>>PS, but it also has a weak contaminating SMase activity.47 Cabbage 
phospholipase D (PLDCab) has a substrate preference for PC≈PE≈PG (phosphatidyl 
glycerol)>>PI>PS.48 Comparison between the effects of SMase vs. PLD would 
distinguish whether the choline headgroup alone or the unique structural features of 
sphingophopholipids contributes to the binding interaction between PMT-N and SM. 
PLDCab caused a decrease in the slow binding Bmax, but had little effect on rapid 
binding component (Figure 2.7E vs. 2.7A, Table 2.1). PLDSc decreased both the rapid 
and slow binding components (Figure 2.7G vs. 2.7A, Table 2.1). The drastic changes 
seen with SMase were not detected with either PLD (Figure 2.7E vs. 2.7C and 2.7G vs. 
2.7C), suggesting that the contribution of SM to PMT-N binding to membranes was due 
to the entire sphingophospholipid structure and not just the choline headgroup alone. 
Effect of trypsin treatment on PMT-N binding to HEK-293T cell membranes. 
Trypsin treatment would remove some cell surface protein components; particularly 
those not present in microdomains or membrane lipid rafts. Trypsin treatment of native 
membranes deceased the slow binding Bmax, but showed little effect on kon or koff 
(Figure 2.7B vs. 2.7A, Table 2.1). The most prominent effects of trypsin were on the 
rapid binding component, where the Bmax decreased by more than half and became 
quickly saturable with a KD of less than one third that for the untreated membranes. 
Trypsin treatment of the membranes that had already been exposed to SMase or 
PLDCab showed a small increase in Bmax for the slow binding component, but did not 
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have an effect on other kinetic parameters of the rapid or slow binding components 
(Figure 2.7D vs. 2.7C, 2.7F vs. 2.7E, Table 2.1). These results implicate a protein 
component in natural membranes for both the rapid and slow binding components; 
however, removal of protein has minimal effect on membranes already depleted of 
choline or phosphocholine headgroups, indicating that protein is only important for PMT 
binding when PMT is also interacting with PC and/or SM in the membrane. 
2.5. Discussion 
Two previous reports indicated that gangliosides, namely GM1, GM2 and GM3, were 
receptors for PMT.25,26 Our results using the TLC-overlay method, indicated that PMT 
did not detectably interact with gangliosides, including GM1, GM2 or GM3, in this 
experimental system. Instead, PMT bound well to asialogangliosides, and in particular 
positively charged phospholipids (PC and PE) and sphingophospholipids (SM). Upon 
further consideration of the experimental conditions used in the previous studies25,26, it 
was noted that the ganglioside concentrations used in those studies was above the 
critical micelle concentration, which might have interfered with the availability of PMT to 
gain access to the cell surface for optimal binding. In addition, the readout of the assays 
in one of the studies25 relied on determination of the downstream mitogenic effect of the 
toxin on cells, which could have been skewed by indirect inhibitory effects on 
mitogenesis caused by the ganglioside mixtures.49-51  
Although we did not observe binding of full-length PMT or PMT-N to gangliosides, 
we did observe, however, binding of PMT-C to gangliosides, specifically GM1 and other 
more polar di- and trisialogangliosides. This suggests that removal of the N-terminus of 
PMT unmasks a ganglioside-binding site of the protein, which could potentially occur 
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during the uptake, endosomal trafficking and/or the translocation process where the 
toxin presumably unfolds. It has been shown that the C1 domain itself can associate 
with the cell membrane.13 Considering that the C1 domain alone has a calculated pI of 
10.2, which would favor binding to negatively charged phospholipids as suggested by a 
preference of PMT-C to PS over PC, it is possible for the C1 domain of PMT-C to have 
affinity for negatively charged gangliosides.  
The finding that PMT and PMT-N bound to positively charged phospholipid or 
sphingophospholipid headgroups on TLC plates was not surprising considering that 
PMT-N has a low pI of 5.1. Indeed, PE, PC and SM corresponded to the three major 
binding components A1, B and C, respectively, present in cell membrane extracts 
(Figure 2.1). However, our finding that PMT-N bound specifically to the choline-
containing PC and SM, but not as well to PE and not at all to PS, suggests that the 
recognition was not due solely to the positive charge of the headgroup. Additional 
binding studies using SPR and pulldown assays with PC vesicles containing SM 
compared to PC alone or PC/PS supported these findings. SM-containing PC liposomes 
resulted in enhanced binding of PMT-N compared to PC alone in the pulldown assay, 
and only when vesicles were doped with 10% LacC, GM1, or 50% PS was equilibrium 
binding enhanced, and thus better exposed phosphocholine headgroups. The difference 
between SM and PC appears to only be kinetic in nature and not as important for 
thermodynamic binding. Analysis of SPR sensorgrams with SM plus PC vesicles 
likewise showed a higher capacity for binding to PMT-N than PC vesicles alone. 
Natural membranes treated with SMase showed the most drastic changes in PMT-N 
binding, with 10-fold increase in the rapid binding Bmax and 2-3-fold increase in both the 
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rapid and slow KD. The increase in KD for the tight slow binding component resulted 
primarily from a decrease in kon, while the increase in the KD for the rapid binding 
component resulted primarily from an increase in koff. This change reflects the fact that 
SM contributes to both rapid and tight binding of PMT-N to membranes. Although it is 
puzzling that loss of binding affinity is accompanied by a dramatic increase in binding 
capacity in the rapid phase, it is possible that the loss of the phosphocholine headgroup 
from SM might result in a reorganization of the membrane to expose more surface area 
and thus expose more low affinity sites for binding or it could distribute low affinity 
binding sites to make them more available. Removal of the phosphocholine headgroup 
is also known to induce the resulting ceramide moieties to laterally segregate into 
microdomains.52 Our TLC-overlay experiments also showed that PMT bound to both 
ceramide I and II. This reorganized ceramide microdomains may be responsible for the 
observed enhanced binding. In contrast, there was a decrease in the slow component 
Bmax, indicating a loss in the number of tight binding components available and further 
implicating the importance of SM for binding. 
To further characterize the role of phosphocholine in binding of PMT to membranes, 
cell membranes were treated with two forms of PLD (PLDSc and PLDCab), both of 
which have a substrate preference of PC and PE, but the PLDSc also contains a 
contaminant that has SMase activity. Treatment with either PLD did not show any 
drastic enhancement of rapid binding nor did it change the kinetic characteristics; 
however, a small decrease in Bmax for both the rapid and slow binding phases was 
observed.  
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SM has recently been implicated in the cellular binding and uptake of the vacuolating 
toxin VacA from Helicobacter pylori.53,54 In these studies, the presence of SM appears 
to be required for VacA entry, since SMase treatment abolished VacA activity while 
adding SM back to cells restored VacA activity. This is in contrast to our findings, which 
suggest that removing the phosphocholine headgroup of SM only altered the binding 
affinity (KD) of PMT by a factor of 3. Indeed, no single treatment of the membranes, by 
SMase, PLD or trypsin, resulted in complete abolishment of PMT binding, with each of 
the treatments resulting in a reduction of about a third of the slow binding component. 
This points to the possibility of multiple coreceptors for PMT binding. However, it is not 
clear whether the observed reduction in KD upon SMase treatment could lead to 
nonproductive, albeit tight binding that might impair the normal endocytic process. 
We found that the kon observed for the slow component of PMT-N binding with the 
natural membranes was about 1,000-fold lower than that reported for CT binding to 
GM1 receptors (103 versus 106 M-1s-1), whereas koff was 100-fold higher, such that the 
overall KD is about 100,000-fold higher (10-7 M for PMT-N binding versus 10-12 M for CT-
GM1 binding).41,43 On the other hand, PMT-N binding to membranes is on the same 
order of that found for BoNT/A binding to GT1b.44 BoNT/A is an example of a toxin 
known to bind to cells through multiple interactions with two different types of 
coreceptors, ganglioside and protein.29  
Considering that PMT-N shares significant sequence similarity with the N-terminal 
regions of the CNFs1 and CNF1 and CNFY have been found to bind to protein (LRP) 
and heavily glycosylated protein (HSPG) receptors21-23, it is not unreasonable to 
propose that PMT-N likewise might have multiple binding components that it interacts 
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with during the internalization process. Such a cellular entry model for PMT might 
involve an initial nonspecific binding to lower affinity but more abundant components 
such as PC that would bring the protein to the cell surface. A more specific binding to 
SM would follow this, along with possible binding to a putative protein coreceptor that 
would then trigger endocytosis. In addition to PC, other membrane lipids might 
contribute to the initial binding, particular since we observed that PMT bound to a 
number of other glycosphingolipids and phospholipids.  
Although trypsin treatment did not completely abolish PMT binding interactions with 
membranes and did not affect the binding kinetics, this does not necessarily rule out the 
possibility of a protein coreceptor for PMT. It is possible that there may be a limitation of 
the number of critical receptors or events involved in toxin uptake, which might be 
mediated through a protein coreceptor. In summary, our data point to an important role 
of SM in PMT binding to membranes, as evidence through four different methods, TLC-
overlay, SM/PC liposome pulldown, SPR of SM/PC liposomes, and SPR of natural 
membranes without or with SMase treatment. Based on our findings, we propose a 
model for PMT interaction with host cells that involves initial low affinity nonspecific 
binding to cells, followed by a more specific, tight binding interaction with SM and 
possibly other membrane components including a putative protein coreceptor. 
2.6. Materials and methods 
Materials. African green monkey kidney (Vero) cells, HEK-293T cells and NG108-15 
cells were obtained from the American Type Culture Collection. [125I]NaI was purchased 
from MP Biomedicals. L-α-phosphatidylcholine (PC), L-α-phosphatidylethanolamine 
(PE), L-α-phosphatidyl-L-serine (PS), sphingomyelin (SM), stearic acid (SA), 1-stearoyl 
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glycerol (MG), 1,2-distearoyl glycerol (DG), Bacillus cereus sphingomyelinase (SMase), 
cabbage phospholipase D (PLDCab, cat# PLD-c), Streptomyces chromofuscus 
phospholipase D (PLDSc, cat# PLD-b), and His-Select Nickel Affinity Gel were obtained 
from Sigma. Cerebroside (Gal-Cer), glucocerebroside (Glc-Cer), lactosylceramide (LC), 
monoasialogangliosides GM1, GM2 and GM3, and porcine and bovine mixed 
gangliosides were obtained from Matreya Inc. Trypsin (Mass Spec Grade) was obtained 
from Promega. The aluminum-backed silica TLC plates were purchased from Whatman. 
All other reagents were obtained from Fisher or RPI, unless otherwise noted. BCA 
protein assay kit was obtained from Pierce. HiTrap-ANX, PD-10, and L1 chip was 
purchased from GE Healthcare Sciences.  
Preparation of recombinant PMT (rPMT). rPMT (1-1268) with an N-terminal His6-tag 
cloned into pTrcHis vector, PMT-N (residues 1-568) with a C-terminal His6-tag cloned 
into pET21 vector, and PMT-C (569-1268) were expressed and purified as previously 
published.6 Briefly, proteins were expressed in E. coli under IPTG induction. Cells were 
harvested and lysed using sonication, and proteins were purified using a nickel affinity 
(His-Select) and anion exchange chromatography (ANX), and then desalted using a 
PD-10 column. Concentrations were measured via BCA assay and verified via 
densitometry on a 10% SDS-PAGE gel.  
Labeling of rPMT, PMT-N and PMT-C with [125I]sodium iodide. A PD-10 column was 
equilibrated by washing with 20 mL of PBS, blocked with BSA (a solution of 10 mg in 1 
mL PBS), then washed again with 20 mL PBS. [I-125]NaI (100 µCi) was added to a 2-
mL screwed-capped centrifuge tube precoated with 50 µg of Iodogen (Pierce), and the 
protein to be labeled (50 µg) was added, followed by PBS for a total volume of 100 µL. 
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The tube was incubated at room temperature for 3 minutes, with occasional swirling. 
The contents of the tube were applied to the PD-10 column, and 10 µL of NaI (1 g/mL) 
was added quickly to the column to dilute any remaining free label. The labeled protein 
was eluted from the column in 12 x 0.5 mL fractions of PBS. Fractions containing the 
labeled protein (#6-9) were combined and mixed with BSA (10 mg in 1 mL of PBS) in a 
screw-capped 15-mL polypropylene tube. The labeled protein was stored at 4ºC until 
use. 
Ames test for phosphate contents in lipid extracts. The phosphate content in 
phospholipids and lipid extracts was determined by using the Ames phosphate assay 55. 
Briefly, 0.01-0.1 mL of sample was mixed with 0.03 mL of 10% Mg(NO3)2 solution in 
absolute ethanol in a 10-mL glass tube. The mixture was dried and ashed by shaking 
the tube over a flame until brown fumes disappeared [Note: This procedure was 
performed behind a safety shield in a fume hood]. After cooling the tubes to room 
temperature, 0.3 ml of 0.5 N HCl was added to each tube and incubated for 15 min at 
95°C. The tubes were allowed to cool down to room temperature and 0.7 ml of reaction 
mixture (6:4:1 ratio of 0.42% ammonium molybdate:water:20% ascorbic acid) was 
added to each tube. The tubes were then incubated at 45°C for 20 min, and the 
absorbance was read at 820 nm. The concentrations of phosphate in the samples were 
determined using a standard curve generated from serial dilutions of a known 
phosphate standard.  
Preparation of total cellular lipids for TLC analysis. Confluent monolayers of Vero, 
HEK-293T or NG108-15 cells were collected, washed and resuspended in PBS (3 mL 
per 150 mm culture dish used). To 1 mL of resuspended cells, 1 ml of a 1:1 
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chloroform:methanol mixture was added, and the lipids were extracted from the cells by 
a combination of sonication, vortexing, and pipetting, followed by incubation at room 
temperature overnight. The mixture was centrifuged at 16,000 xg for 5 minutes, and the 
supernatant was transferred to a new tube, dried by SpeedVac, and stored at -20°C 
until use. 
Thin layer chromatography for phospholipids and overlay with radiolabeled rPMT, 
PMT-N or PMT-C. Aluminum-backed silica-gel TLC plates (6.5 cm x 10 cm) were 
loaded with lipid samples (50 nmoles phosphate equivalent) and dried for 1 hr under 
vacuum in a desiccator. The plates were then developed in a TLC chamber with a 
solvent system of 80:20:2, 70:25:4, or 5:4:0.6 (v/v/v, chloroform/methanol/0.05% CaCl2 
in distilled water). Plates were then dried and either stained with 10% cupric sulfate 
solution (in 8% phosphoric acid) or used for overlay experiments. For overlay 
experiments, the dried plates were blocked in 1% BSA in PBS (10 mM Na2HPO4, 1.8 
mM KH2PO4, 136 mM NaCl, 2.6 mM KCl). The BSA-blocked TLC plates were 
transferred into an overlay solution (125I-labeled rPMT, PMT-N, or PMT-C in 15 ml PBS) 
and incubated for 2 hr at 37oC with a gentle rocking. Plates were then washed four 
times with ice-cold PBS and dried for 1 hr by heating gently under a 40-Watt light bulb. 
The plates were then stored in phosphorimager cassettes (Molecular Dynamics) 
overnight, and the image was visualized using a phosphorimager scanner (Fuji FLA-
3000) and analyzed with Fujifilm Image Gauge software. After the phoshorimage was 
acquired, all the lipid spots on the TLC plate were visualized by cupric sulfate staining. 
The corresponding CuSO4-stained images were recorded with a desktop scanner and 
compared to the phosphorimager-generated images. 
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Purification of lipid components in cell membrane. Large-scale lipid purification was 
performed using silica-gel chromatography. Fresh bovine trachea (~300 g) were diced 
and placed in a blender with 700 mL distilled water. After blending the tissues, the 
mixture was centrifuged for 5 min at 2,500 xg. The supernatant was discarded. Four 
samples of 20 g each were resuspended in 100 ml of a 1:1 mixture of 
chloroform:methanol (v/v). After overnight extraction on a rocker at room temperature, 
the insoluble fractions were removed by centrifugation for 5 min at 2,500 xg. The 
extracts were then combined and evaporated under vacuum. The dried lipids were 
resuspended in 50 mL of a mixture of 1:1 chloroform:methanol (v/v) and loaded onto a 
column containing 40 ml of silica gel. Phospholipid components A, B, C and D were 
eluted from the column with a 10% stepwise chloroform/methanol gradient from 100:0 to 
0:100 (v/v), and 10 ml fractions were pooled, according to TLC analysis, and allowed to 
evaporate in a fume hood. Some of the pooled fractions were further purified with 
appropriate chloroform/methanol mixtures to resolve into additional components. 
Preparation of liposomes for solution binding. To prepare the liposomes, 0.1 g of 
cholesterol was mixed with 0.9 g of PC only or PC/PS (75:25), PC/SM (75:25). The 
mixtures were dissolved in 50:50 chloroform/methanol (v/v) and dried down in glass 
tubes under vacuum for 1 hr using a SpeedVac. The thin layers of dried lipids were then 
rehydrated with 1 mL of ice-cold PBS for 1 hr and resuspended by vigorous vortexing (2 
x 30 sec). The opaque, large multi-lamellar vesicles (MLV) were then sonicated by 
using a bath ultrasonicator (Branson) for 10 min to produce small uni-lamellar vesicles 
(SUV). The clear SUVs so prepared were then incubated with 10 µg of purified rPMT for 
1 hr at 4°C and centrifuged for 10 min at 30,000 xg. The supernatants were saved, 
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while the pellets were resuspended with 100 µL SDS-PAGE sample buffer and an 
aliquot of supernatant was mixed with two volumes SDS-PAGE sample buffer. Equal 
volumes of SDS-PAGE sample preparations from supernatants and pellets were 
separated by 10% SDS-PAGE. The relative amounts of rPMT in the supernatants and 
pellets were determined from the densitometry of Coomassie Blue-stained gel images 
and analysis with ImageJ software. Confirmation was done by western blot by diluting 
samples five-fold before loading onto the gel. A PMT antibody specific for the n-terminal 
sequence was used in conjunction with goat anti-rabbit antibody and a GE Healthcare 
Western Blotting Visualization Kit.   
Preparation of liposomes for surface plasmon resonance. Lipids, PC only, PC/PS 
(1:1) or PC/SM (1:1), in powder form were weighed and re-suspended in 10 mM tris-HCl 
buffer, pH 7.4, to a final concentration of 20 mM of lipid. The flask was purged with 
nitrogen and sealed before sonication for 1 hr using bath sonicator (Branson 1200). The 
resulting vesicles were extruded 19 times through a 100-micron pore using the extruder 
kit from Avanti Polar Lipids. The small unilamellar vesicles were aliquoted, flash frozen 
and stored at -20°C before use.  
Isolation of membranes from HEK-293T cells. Membranes were purified using a 
modified protocol utilizing density centrifugation to isolate membrane fractions from 
whole cell lysates.56 Briefly, HEK-293T cells grown to confluence in DMEM with 10% 
BGS under 5% CO2 at 37°C were harvested and centrifuged at 2,500 xg. A volume of 2 
mL of cell pellets was resuspended in 20 mL of tris-Mg2+ buffer (TM, 100 mM tris-HCl, 
10 mM MgSO4, pH 7.4) and homogenized using 10 strokes of a Dounce homogenizer, 
and converted into an 8.5% sucrose solution by addition of 4.5 mL of 60% sucrose. The 
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membranes and whole cells were pelleted for 15 minutes at 2,000 xg and washed 3x 
with 40 mL of TM with 8.5% sucrose. Sucrose was added to the pellet to make a 45% 
sucrose solution. An equal volume of 40%, 35% and 8.5% sucrose solutions were 
overlayed on top in sequence. The solution was centrifuged for 10 min at 70,000 xg at 
4oC using an SW40Ti rotor. The band at the 35-40% interface was collected and diluted 
with two volumes of TM buffer, pH 8.6, and centrifuged at 2,500 xg for 20 min. The 
ghosts were resuspended in 6 mL of TM-sucrose solution. The membranes were 
sonicated briefly (10 sec at power level 5.5 using Sonifier Cell Disrupter, Model 185D, 
Heat Systems, Ultrasonics Inc.) to form vesicles. Residual amount of heavy organelles 
was pelleted by centrifugation at 2,000 xg for 15 minutes. The supernatant was 
collected, and the protein content was measured via BCA assay. Vesicles were flash 
frozen and stored at -20o C until use. 
Surface plasmon resonance analysis using Biacore 3000. All four flow cells in the 
L1 chip were primed with 20 mM CHAPS, pH 7.4, between trials. All trials were run at 
25° C. Membrane extracts were loaded by lowering the pH to ~4.5 using sodium 
acetate buffer and injecting at 2 µL/min in Biacore buffer (autoclaved, sterile filtered and 
degassed 50 mM tris-HCl, 150 mM NaCl, pH 7.4). Reconstituted membrane vesicles 
were loaded at a concentration of 500 µM in Biacore buffer at 5 µL/min. The loading 
was continued until less than 1 RU/sec baseline increase was observed (~30-45 min). 
The surface of the membrane was then conditioned using 1 M NaCl (at 20 uL/min for 2 
min). Non-specific binding sites were blocked with BSA (0.5 mg/mL, at 5 uL/min for 5 
min). After re-equilibration of the L1 chip with buffer, increasing concentrations of PMT-
N were added to the L1 chip. Concentrations of PMT-N injected onto the L1 chip 
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surface were 7.5 nM, 75 nM, 750 nM, 3.75 µM, or 7.5 µM, and in some cases, where 
necessary, 15 µM at 5 µL/min for 4 min for all reconstituted vesicles and for 5 min for all 
cell membrane isolates (see Figure 2.6A). Dissociation for at least two minutes by 
washing with Biacore buffer without PMT occurred between injection of the next highest 
concentration of PMT. Chips were washed between experiments thrice with 20 mM 
CHAPS, pH 7.4, followed by 1X Trypsin-EDTA solution (Sigma Aldrich).  
Treatment of membranes on L1 chip with enzymes. Membranes on the L1 chip were 
treated with 0.1 U/µL of SMase, PLDCab, or PLDSc or with 0.20 µg/µL of trypsin in 
Biacore buffer by applying to the surface at a flow rate of 1 µL/min for 30 min. Enzymes 
were removed by washing with 1 M NaCl, followed by Biacore buffer. These enzyme-
treated membranes were used for SPR experiments. In some instances, after 
sequential PMT-binding/dissociation events using SMase or PLDCab-treated 
membranes, the membrane were then treated with trypsin (0.2 µg/µL) at a flow rate of 1 
µL/min in Biacore buffer for 30 min to remove residual PMT-N and cleavable protein 
components of the membrane, followed by washing with Biacore buffer. The resulting 
lipase/trypsin-treated membranes were then used for further SPR experiments for PMT-
N binding.  
Analysis of SPR sensorgrams. The sensorgram of each association (binding) phase 
was analyzed according to a two-component exponential curve model, where the 
resonance signal R(t) at time point t is 
 
One of these two components represents a rapid on-off binding process and the other a 
slow on-off binding. Each of these two components can be further resolved, according 
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to the kinetic analysis of O’Shannessy et al.45, where the resonance signal R(t) at time t 
is 
 
and where C is the concentration of ligand, Rmax is the maximum resonance signal 
corresponding to the maximal binding Bmax, and kon and koff are the association and 
dissociation rates, respectively. We added a ligand concentration-dependent correction 
term, ∆Rc, for Rmax. For the slow on-off phase, bound ligand was not completely 
dissociated before a higher concentration of ligand was applied in sequence. To correct 
for this, a baseline adjustment was made. This correction was equal to the residual 
resonance R’min after treatment of ligand at the previous concentration C’, which was 
subtracted from the Rmax and added back into the total signal. For the rapid on-off 
component, an equilibrium was quickly reached, so R’min = 0. The detailed curve fitting 
equation was described as 
 
For the dissociation phase, the sensorgram was treated as a sum of two dissociation 
components and described as 
 
The segments from a sensorgram of 4 or 5 continuous association events were 
simultaneously fitted to equations 1, 3 and 4 with constant Rmax(A), kon(A), koff(A) and 
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Rmax(B); kon(B), koff(B) and 5 concentration-dependent ∆RC values for Rmax(A) and for 
Rmax(B). The curve fitting was solved using a nonlinear least squares method calculated 
in Solver in Excel through minimization of the sum of the squares. For the rapid on-off 
component, the ligand concentration-dependent apparent maximum for each 
concentration at equilibrium, Rmax(C) = Rmax + ∆RC , was fitted to a thermodynamic 
equilibrium model, according to the Langmuir isotherm, 
 
where KD was the dissociation constant at thermodynamic equilibrium. 
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 CHAPTER 3 
Assignments of the Membrane Localization Domains from Pasteurella 
multocida toxin and Vibrio vulnificus MARTX toxin 
 3.1. Notes and Acknowledgments 
This chapter is in part adapted with kind permission from the Journal of Biomolecular 
NMR Assignments from the following publications, entitled "Backbone and side-chain 
dassignments of an effector membrane localization domain from Vibrio vulnificus 
MARTX toxin", 2013, Epub, authors: Michael C. Brothers, Brett Geissler, Grant S. 
Hisao, Brenda A. Wilson, Karla J.F. Satchell, and Chad M. Rienstra, and "Backbone 
and side-chain resonance assignments of the membrane localization domain from 
Pasteurella multocida toxin", 2013, Epub, authors: Michael C. Brothers, Brett Geissler, 
Grant S. Hisao, Karla J.F. Satchell, Brenda A. Wilson, and Chad M. Rienstra. This work 
was supported by NIH awards AI051490 and AI092825 (to K. J. F. S.), Burroughs 
Wellcome Fund award (to K. J. F. S.), NIH/NIAID grant AI038396 (to B. A. W.), 
University of Illinois grant (to C. M. R.), and NIH/CBITG (T32 GM070421) and the 
Department of Homeland Security Fellowship (to M. C. B). The authors thank Dr. 
Lingyang Zhu from the University of Illinois School of Chemical Sciences NMR Facility 
for technical assistance. 
3.2. Backbone and Side-chain Resonance Assignments of the Membrane 
Localization Domain from Pasteurella multocida Toxin  
3.2.1. Biological Context of Solution State 
Within the C1 domain of PMT, a 4HB spanning residues 590-670 has been identified 
as a conserved MLD8,9 that is necessary to target the C3 deamidase domain to the 
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plasma membrane when exogenously expressed in mammalian cells.8,9 A C-terminal 
fragment containing C1-C2-C3 and the MLD alone bind anionic phospholipids in lipid-
binding assays.10 These anionic phospholipids are found in high abundance in both the 
late endosome and in the inner leaflet of the plasma membrane, where the G-protein α-
subunit target of PMT is located.7 
The MLD from PMT (MLDPMT) is homologous to domains within at least 24 other 
bacterial toxins and effectors.11 These domains are all thought to direct their associated 
catalytic domains to the host plasma membrane where their intracellular target is found. 
Importantly, only four proteins containing homologous MLDs have solved structures: 
PMT (PDB 2EBF), TcsL (PDB 2VL8), TcdA (PDB 3SS1), and TcdB (PDB 2BVL); all 
other structural models have been generated by structure prediction algorithms based 
on these four crystal structures.11 Therefore, it is key to validate that the solution and 
membrane bound-states contain the same four helices that are present in the crystal 
structure to confirm the physiological relevance of these studies and the role of these 
bundles in the context of the larger toxins.  
Here, we report the assignments of MLDPMT in the solution state. Secondary 
chemical shift analysis using TALOS+ demonstrates that MLDPMT has similar secondary 
structure elements to those found in the crystal structure of the C-terminus of PMT. 
Resonance assignments will facilitate further studies to examine the structure and 
dynamics of membrane binding by MLDPMT. 
3.2.2. Methods and Experiments 
Recombinant protein expression and purification 
We cloned residues 589-668 (residues 2-81 of the MLDPMT construct) flanked by an 
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N-terminal methionine and a C-terminal GLE linker sequence attached to a His6-tag into 
the plasmid pYCpet. Uniformly labeled 13C, 15N MLDPMT was expressed in E. coli 
BL21(DE3) cells (Promega, Fitchburg, WI) from plasmid pYCpet. MLDPMT was purified 
using a modification of the previously described method for other MLDs.10,11 Briefly, a 4-
mL starter culture was grown at 37°C to OD600 = 2 in LB. 1 mL of the bacteria were then 
harvested and resuspended in 1 mL of M9 salt buffer, and then inoculated into a flask 
containing 200 mL of the labeling medium containing 13C, 15N-BioExpress, U-13C-
glucose, and 15N-NH4Cl (Cambridge Isotopes Laboratories, Inc., Andover, MA).12 
Specifically, 13C, 15N-BioExpress (10X stock solution) was diluted to 0.1× in M9 minimal 
media at pH 7.5 containing 2 g/L U-13C-glucose and 3 g/L U-15N- NH4Cl. The culture 
was grown at 37°C until the OD600 reached ~0.8. Expression of MLDPMT was induced 
with 0.4 mM (0.1 mg/mL) isopropyl β-D-1-thiogalactopyranoside for 4 h. The cells were 
then harvested and lysed by sonication (6 x 30 second pulse followed by 1 min rest) on 
ice in 100 mL of lysis buffer (20 mM bis-tris, 500 mM NaCl, pH 6.0 buffer containing 1% 
IGEPAL (w/w), 0.1 mg/mL benzamidine, 0.05 mg/mL PMSF (dissolved in 1 mL of 
acetone and added drop-wise to stirred solution), 1:1000 protease inhibitor cocktail in 
DMSO (Sigma), 0.02 mg/mL DNAse/RNAse, 10 mM imidazole, and 2.5% glycerol). The 
cell debris was subsequently pelleted (RCF ~32,000). The supernatant was decanted 
and purified via Ni2+-affinity chromatography (HiPrep 16/160, GE Biosciences, 
Piscataway, NJ) by first running the supernatant through the column twice, then 
washing with chilled 20 mM bis-tris, pH 6.0 buffer, containing 500 mM NaCl and 10 mM 
imidazole, and then eluted using 8 x 5-mL fractions of chilled 20 mM bis-tris, pH 6.0 
buffer, containing 500 mM NaCl and 200 mM imidazole. The eluent was then 
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concentrated to a volume of ~3 mL using an Amicon Ultra-15 centrifugal filter unit with 
MWCO of 3K (Millipore, Billerica, MA). The 3-mL volume concentrated from the nickel 
column was then loaded into a 5-mL sample loop and run through a Sephacryl-S100 
size exclusion column with a column volume of 120 mL to perform both buffer exchange 
as well as to further purify the protein using 20 mM bis-tris buffer, pH 6.0, in 500 mM 
NaCl (GE Biosciences, Piscataway, NJ). The column was run at a flow-rate of 0.5 
mL/min for optimal separation, although we also ran at 1.0 mL/min successfully for 
MLDPMT, with one peak observed in both cases. We observed the protein come off the 
size exclusion column at around 70 mL, with the peak consisting of ~5 fractions of 3-mL 
volume. The fractions corresponding to the protein peak were then re-concentrated 
using an Amicon Ultra-15 centrifugal filter with MWCO of 3K (Millipore, Billerica, MA) to 
a volume of less than 1 mL. This resulted in >99% purity, and a yield of 40-60 mg/L 
MLDPMT.  The protein was stored as a stock solution of 25-60 mg/mL in 20 mM Bis-tris 
buffer, pH 6.0, containing 500 mM NaCl either at 4ºC or flash-frozen using liquid 
nitrogen and then stored at -80ºC. The stock concentration of MLDPMT was checked for 
purity using SDS-PAGE with 16% tris-tricine gels run at 40 milliamps constant current 
for 120 minutes followed by staining (see chapter 4.4, Liposome Pulldown Assay for 
protocol). The protein was quantified using the BCA assay (Pierce). Briefly, the stock 
MLDPMT solution was diluted 5:1000 into distilled water, followed by addition of 20 µL of 
the now diluted protein solution into a 96-well plate in triplicate. A volume of 200 µL of 
reagent from the BCA kit was then added (50:1 A:B) and the solution was allowed to 
incubate for 30 minutes. A plate reader was then used to measure absorbance at 564 
nm. This was compared each time to concentrations of bovine serum albumin ranging 
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from 20 µL of 2 mg/mL to 20 µL of 0.0625 mg/mL (in triplicate), as described in the 
manufacturer's kit manual. The BCA reagent was added to both the unknown protein 
concentration and the BSA standards within 1 minute of each other to minimize error.  
The total amount of protein in the BSA standard (x in µg) was plotted against the 
average absorbance (y), and this equation was fit using Microsoft Excel to generate a 
best-fit line. The absorbance of the diluted MLDPMT solution was then used to determine 
the amount of protein present, which was then used to back-calculate the concentration 
of the protein in the MLDPMT stock solution. 
NMR spectroscopy 
Solution NMR spectra were acquired at the School of Chemical Sciences NMR 
Facility (University of Illinois at Urbana-Champaign) on a Varian INOVA 600 
spectrometer equipped with a 5-mm, triple resonance (1H-13C-15N) triaxial gradient 
probe, using VNMRJ version 2.3 with the BioPack suite of pulse programs. Spectra 
were acquired at 30°C on U-13C, 15N samples containing 1 mM (10 mg/mL) MLDPMT, 
100 mM NaCl, 20 mM bis-tris, 3 mM EDTA, 0.01% DSS, 10% D2O; the MLDPMT 
samples used for solution NMR were prepared by diluting one part protein stock 
solution (5 mM protein, 20 mM bis-tris, pH 6.0 buffer with 500 mM NaCl) into four parts 
pre-mixed buffer (20 mM bis-tris, pH 6.0 buffer containing 3.75 mM EDTA, 0.0125% 
DSS, and 12.5% D2O). Samples were concentrated again, if necessary, to 10 mg/mL 
protein using an Amicon Ultra-2 spin-concentrator run at 3,220 rcf in a swinging-bucket 
rotor. The pH of the 0.33 M EDTA solution was adjusted to 6.0 before addition to the 
NMR sample. The final solution was ~500 µL and contained 1 mM MLDPMT in 20 mM 
bis-tris, pH 6.0 buffer with 100 mM NaCl, 3 mM EDTA, 0.01% DSS, and 10% D2O (v/v). 
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This sample was used for NMR experiments.  A similar protocol was used for deuterium 
exchange, ,except that the initial stock solution of protein was diluted to 2 mL with 
sterile-filtered D2O containing 5 mM bis-tris, pH 6.0 buffer, with 1 mM EDTA and 500 
mM NaCl for a final concentration of 0.1 mL stock protein at 50 mg/mL in 1.9 mL D2O 
solution. This solution was spin-concentrated to a volume of 200 µL and re-diluted twice 
with a solution of 5 mM bis-tris, pH 6.0 buffer, with 1 mM EDTA, 500 mM NaCl, and 
100% D2O to a total volume of 2 mL. After concentrating again to a volume of ~200 µL, 
the solution was diluted 5x (1 part protein solution, 4 parts buffer) into a solution of 5 
mM bis-tris, pH 6.0 buffer with 1 mM EDTA and 0.0125% DSS. This solution was then 
concentrated down to a volume of ~500 µL to yield a final solution of ~1 mM MLDPMT in 
5 mM bis-tris, pH 6.0 buffer, with 100 mM NaCl, 1 mM EDTA, 0.0125% DSS and >98% 
D2O that was used in the carbon-edited TOCSY and NOESY experiments.   
To verify the stability of the samples, 2D 1H-15N HSQC or 2D 1H-13C HSQC spectra 
were acquired between each pair of triple-resonance experiment used for assignments. 
The following standard suite of gradient-based heteronuclear triple resonance 3D 
spectra were employed for backbone assignments: (HNCO, HN(CA)CO, HNCACB, 
CBCA(CO)NH).13-16 Further, 15N-NOESY-HSQC, 15N-TOCSY-HSQC, 13C-HCCH-
TOCSY, CC(CO)NH, and 13C-NOESY-HSQC were utilized to obtain side-chain 
resonance and proton assignments.17 Spectra were processed with NMRPipe18 and 
analyzed in Sparky.19   
3.2.3. Extent of Assignments and Data Deposition 
The data sets enabled assignment of 99% of all backbone and side-chain carbon 
atom assignments including 99% of the HN, N, Cα, Cβ, C’ backbone assignments 
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(excluding P amides) for MLDPMT. The assignments are deposited in the Biological 
Magnetic Resonance Bank (BMRB) under accession number 18565. The 1H-15N 
gradient HSQC spectrum (Figure 3.1, left) demonstrates good dispersion, consistent 
with a folded structure. Of the 77 expected backbone amide chemical shifts belonging to 
MLDPMT 76 were observed.  
 
TALOS+20 analysis demonstrates four helices, consistent with the homology model 
of MLDPMT based on the crystal structure of PMT (Figure 3.1, right). The helices consist 
of H1 (residues 6-12), H2 (residues 22-36), H3 (residues 40-61) and H4 (residues 67-
81), connected by loops L1 (residues 13-21), L2 (37-39), and L3 (62-66). The majority 
of unassigned residues belong to the N-terminal leader sequence or C-terminal His-tag. 
	  
	  
Figure 3.1:  Solution assignments and secondary structure of MLDPMT. (Left) 1H -15N 
2D HSQC spectrum of MLDPMT acquired at 600 MHz (1H frequency) at pH 6.0. 79 
amide resonances are observed and assigned. (Right) Secondary structure elements 
of the MLDPMT identified by TALOS+ compared to the secondary structure from the 
crystal structure of the MLD from the C1 domain of PMT.2,21 Plotted are the Phi (Φ) 
(black circles) and Psi (Ψ) (gray squares) backbone torsion angles as predicted by 
TALOS+.8,20 Along the x-axis is a cartoon representation of the secondary structure 
based on the crystal structure [2EBF (green)8,20] and the secondary structure 
predicted by TALOS+ (blue). The residue numbers from the construct and those from 
the crystal structure of PMT (in parenthesis) are both listed along the x-axis. 	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The exception is Glu65, for which the amide HN and N signals are missing. TALOS+ 
analysis indicated that Glu65 is in loop L3; this loop is proposed to be important for 
membrane binding through hydrophobic and electrostatic interactions.11 Resonance 
assignments will facilitate further studies to understand the dynamics and conformations 
of loops L1, L2, and L3 residues in the free and membrane-bound states. 
3.3 . Extent of the Assignments of the Micelle Bound State of MLDPMT 
3.3.1. Biological Context of the Micelle State 
  Membrane localization domains as stated in chapter 3.2.1 target anionic 
phospholipids at the inner leaflet of the cell. LMPG serves as a suitable mimetic that is 
compatible with assignment of membrane proteins.16 In the case of MLDPMT, the target 
of the attached deamidase effector domain is the α-subunit of G-proteins, which are 
found associated to the inner leaflet of the membrane. We hypothesize that membrane 
targeting may require a conformational change. Thus, the backbone assignments and 
calculated dihedral angles are important initial steps towards determining the topology 
of the membrane-associated state. 
 3.3.2. Methods and Experiments 
 Proteins were expressed and purified as discussed in chapter 3.2.2. The mixed 
protein-LMPG micelle sample was prepared by addition of dry LMPG powder (36 mg) 
into a volume of 500 µL of 1 mM MLDPMT in 5 mM bis-tris, pH 6.0 buffer, containing 500 
mM NaCl, 3 mM EDTA, 0.01% DSS, and 10% D2O (v/v). The spectra acquired showed 
reasonable dispersion and linewidths. Similar spectra were obtained from samples 
prepared in the following alternative approach.  First 50 µL of 50 mM tris-HCl and 50 
mM bis-tris, buffered to pH 7.0 was added to a volume of 500 µL of 1 mM MLDPMT in 5 
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mM bis-tris, pH 6.0 buffer, containing 100 mM NaCl, 3 mM EDTA, 0.01% DSS, and 10% 
D2O (v/v). 36 mg of LMPG powder was then added and spectra were acquired at 
various LMPG concentrations. The spectra from the first approach (Figure 3.3) 
appeared most similar to ~100 mM LMPG buffered to pH 7.0 (Figure 4.6). We used the 
following experiments to perform backbone assignments: HNCA, HNCO, HN(CA)CO, 
HN(CO)CA, HNCACB, CBCA(CO)NH, and CCONH 3D experiments, as well as the 
corresponding 2D experiments. All spectra of MLDPMT in the presence of LMPG micelles 
were acquired at 40ºC to minimize the global correlation time and T2 relaxation rate. 
 3.3.3. Extent of Assignments 
Linewidths for the MLDPMT bound to LMPG are approximately 50% greater than that 
observed in the absence of micelles (Figure 3.2, left). Due to the congestion of peaks, 
assignments were more challenging to achieve, but we were still able to assign most of 
the heavy atoms (93.2%) and nearly all of the backbone chain (98.7%). The missing 
side-chain heavy atoms were either CD or CE atoms in R, K, and I residues (i.e. side-
chain carbons 4-5 polarization transfers away from the amide) or next to the two P; the 
missing amide came from residue I20, which appears to be in a hinge region between 
helix H1 and loop L1 and thus could be participating in either amide exchange or loop 
dynamics.  
The dihedral angles obtained from TALOS+ analysis showed differences from the 
micelle-free state mainly in loop residues (Figure 3.2, right). The major change in the 
angles occurs around loops L1, L2, and L3. In loop L1, the 9-residue loop L1 observed 
in the solution structure is truncated to GKP.. While loop L2 still is predicted according 
to TALOS+, the dispersion in the angles predicted by TALOS+ is considerably different 
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from the free state (chapter 4). Loop L3 appears to adopt something similar to a hairpin 
loop type geometry based off the change in angles, but no significant change in the 
number of residues involved in the loop is observed unlike in loop L1. The data indicate 
that there is a significant change in the geometry and conformation of the loop residues 
within MLDPMT upon exposure to anionic micelles. The complete structure determination 
will require further experiments discussed in chapter 3.7.  
 
 
 
 
 
	  	  
Figure 3.2:  Micelle assignments and secondary structure of MLDPMT. (Left) 1H -15N 
2D HSQC spectrum of MLDPMT bound to LMPG micelles (150 mM LMPG: 1 mM 
MLDPMT) acquired at 600 MHz (1H frequency) at pH 7.0. Of the 77 expected core 
amide resonances 76 are observed and assigned. (Right) Secondary structure 
elements of the micelle bound MLDPMT identified by TALOS+ compared to the 
TALOS+ results from the solution NMR structure of the MLDPMT.21  Plotted are the 
Phi (Φ) (black circles) and Psi (Ψ) (gray squares) backbone torsion angles as 
predicted by TALOS+.21  Along the x-axis is a cartoon representation of the 
secondary structure based on the solution NMR structure [Solution (blue)] and the 
secondary structure predicted by TALOS+ for the micelle bound state (light blue). 
The residue numbers from the construct for the solution and micelle spectra of PMT 
(in parenthesis) are both listed along the x-axis. 	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3.4. Backbone and Side-chain Assignments of an Effector Membrane Localization 
Domain from Vibrio vulnificus MARTX Toxin  
3.4.1. Biological Context of the Solution State 
MARTX toxins are produced by an array of known bacterial pathogens, including 
Vibrio cholerae and Vibrio vulnificus. The hallmark of all MARTX toxins is the presence 
of a cysteine protease domain (CPD) that, following translocation into host cells and 
binding to inositol hexakisphosphate (IP6), cleaves the full-length toxin to release 
effector domains from the central portion of the toxin.  
 The MARTX toxin encoded by V. vulnificus (MARTXVv) is a 5206 amino acid protein 
toxin that causes destruction of the intestinal epithelium during infection.21 The toxin 
carries 5 distinct toxic effector domains that confer a variety of activities to V. vulnificus 
including cytolysis, actin depolymerization, RhoGTPase-inactivation, caspase 3/7-
dependent apoptosis, and induction of reactive oxygen species.22 Two of these 
domains, the Rho-inactivation domain (RID) and a domain of unknown function 5 
(DUF5) have N-terminal MLDs, although only the MLD associated with DUF5 
(MLDVvDUF5) is a 8.8 kDa, 79 residue domain that retains full functionality during in vivo 
membrane localization and binding to anionic lipids.10 Substitution of two basic residues 
for alanine (K15A or R66A) or a key phenylalanine to asparagine in the loop L1 region 
(F17N) significantly reduces phospholipid binding and plasma membrane localization, 
implicating these as important in membrane association for MLDVvDUF5.10 Importantly, 
anionic phospholipids are found in high abundance in the late endosome and in the 
inner leaflet of the plasma membrane, where DUF5 is presumably exerting its biological 
function.23  
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The conserved region of the MLD is 79 residues in length; homology models of 
MLDVvDUF5 have been generated on the basis of the crystal structures of related MLDs 
from PMT (2EBF) and the clostridial glucoslyating toxins TcdA (3SS1), TcdB (2BVL), 
and TcsL (2VL8). However, the relatively low sequence identity among the MLDs (often 
< 50%) would indicate that future studies of MLDVvDUF5 would benefit from experimental 
data to determine the structures and verify the implied homology. Moreover, NMR 
studies will help to elucidate the significance of conserved residues within the MLD, 
including basic residues such as K15 and R66 as well as hydrophobic helices and 
residues, including Y25.  
Here, we report the resonance assignments of the backbone and side-chain atoms 
(95%) of MLDVvDUF5 in solution. Secondary chemical shift analysis using TALOS+ 
demonstrated that MLDVvDUF5 has similarity to that predicted by homology modeling.11 
Resonance assignments will enable studies to determine the mechanism of MLD-
membrane association.  
3.4.2. Methods and Experiments 
Recombinant protein expression and purification 
Uniformly labeled 13C, 15N MLDVvDUF5 was expressed in E. coli BL21(DE3) cells 
(Promega, Fitchburg, WI) from the pYCpet plasmid encoding the MLDVvDUF5 gene using 
previously published conditions.10,11 Briefly, a starter culture in 4-mL LB was grown at 
37°C to an OD600 = 2, from which 1 mL of the culture was harvested and resuspended 
in 1 mL of M9 salt buffer (64 mM phosphate, pH 7.4 buffer with 20 mM KCl and 200 mM 
NaCl), and then inoculated into a flask containing a volume of 200 mL of the labeling 
medium with 13C, 15N-BioExpress, U-13C-glucose, and 15N-NH4Cl (Cambridge Isotopes 
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Laboratories, Inc., Andover, MA).12 Specifically, 13C, 15N-BioExpress (10X stock 
solution) was diluted to 0.1× in M9 minimal medium, pH 7.5, containing 2 g/L U-13C-
glucose and 3 g/L U-15N NH4Cl. The culture was grown at 37°C to an OD600 ~0.8. 
Expression of MLDVvDUF5 was induced for 4 h with 0.4 mM (0.1 mg/mL) isopropyl β-D-1-
thiogalactopyranoside. The resulting labeled protein was isolated and purified as 
previously published.10,11 The cells (2L) were then harvested and lysed by sonication (6 
x 30-second pulse with 1 min intervals on ice) in a volume of 100 mL of lysis buffer (50 
mM tris-HCl, pH 7.4 buffer, with 500 mM NaCl, 1% IGEPAL (w/w), 0.1 mg/mL 
benzamidine, 0.05 mg/mL PMSF (dissolved in 1 mL of acetone and added drop-wise to 
stirred solution), 1:1000 protease inhibitor cocktail in DMSO (Sigma), 0.02 mg/mL 
DNAse/RNAse, and 2.5% glycerol). The cell debris was subsequently pelleted (RCF 
~32,000) for 2 hours at 4°C, and the supernatant was decanted. The supernatant was 
purified by Ni2+ affinity chromatography, as described in chapter 3.2.2., with the 
exception of using 50 mM tris-HCl, pH 7.4 buffer, instead of 20 mM bis-tris, pH 6.0 
buffer (HiPrep 16/160, GE Biosciences, Piscataway, NJ). The eluent was concentrated 
using an Amicon Ultra-15 centrifugal filter unit with a MWCO of 3K (Millipore, Billerica, 
MA), and then separated by Sephacryl-S100 size exclusion chromatography, as 
described in chapter 3.2.2, except using 50 mM tris-HCl, pH 7.4 buffer, with 500 mM 
NaCl as elution buffer (GE Biosciences, Piscataway, NJ). Two major peaks were 
observed at 0.5 mL/min using a 120-mL column volume, corresponding to monomer (at 
~60 mL) and dimer (at ~70 mL) peaks. However, upon heating to 30ºC, the dimer 
population was reduced (see chapter 5.3.2), and thus the fractions containing both 
peaks were pooled and concentrated (~7 fractions corresponding to volumes 60 mL to 
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80 mL). The protein was concentrated again to a volume of <1 mL using an Amicon 
Ultra-15 centrifugal filter with a MWCO of 3K (Millipore, Billerica, MA). This resulted in 
>99% purity based on SDS-PAGE analysis with a yield of 40-50 mg/L of 1 mM U-13C, 
15N-labeled MLDVvDUF5. The protein was stored as a stock solution of 25-60 mg/mL in 50 
mM tris-HCl buffer, pH 7.4, with 500 mM NaCl, stored at 4ºC or flash-frozen using liquid 
nitrogen and stored at -80ºC. Protein concentrations were determined using the BCA 
assay as described in chapter 3.2.2.   
NMR spectroscopy 
 Solution NMR spectra were acquired at the School of Chemical Sciences NMR 
Facility (University of Illinois at Urbana-Champaign) on a Varian INOVA 600 
spectrometer equipped with a 5-mm, triple resonance (1H-13C-15N) triaxial gradient 
probe, using VNMRJ version 2.3 with the BioPack suite of pulse programs.  
Spectra were acquired at 30°C on U-13C, 15N samples containing 1 mM (10 mg/mL) 
MLDVvDUF5 solutions with 20 mM tris-HCl buffer, pH 7.4, with 500 mM NaCl, 3 mM 
EDTA, 0.01% DSS, and 10% D2O; MLDVvDUF5 samples for solution NMR were prepared 
by diluting the protein stock solution (5 mM protein, 500 mM NaCl, 50 mM tris-HCl pH 
7.4) by 5X into a pre-mixed buffer (12.5 mM tris-HCl, pH 7.4 buffer, with 3.75 mM 
EDTA, 0.0125% DSS, 500 mM NaCl and 12.5% D2O) and if necessary, concentrated 
again using an Amicon Ultra-2 spin-concentrator run at 3,220 rcf. This resulted in a final 
solution of ~500 µL containing 1 mM MLDVvDUF5 in 20 mM tris-HCl, pH 7.4 buffer, with 
500 mM NaCl, 3 mM EDTA, 0.01% DSS, and 10% D2O (v/v). This sample was used for 
NMR experiments.  A similar protocol was used for the deuterium back exchange, 
except that the initial stock solution of protein was diluted to 2 mL into sterile-filtered 
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D2O containing 5 mM tris-HCl, pH 7.4 buffer, with 1 mM EDTA and 500 mM NaCl for a 
final concentration of 0.1 mL stock protein in 1.9 mL D2O solution). During the final 
concentration step, the solution was concentrated to a volume of ~500 µL to yield a final 
solution of ~1 mM MLDVvDUF5, 5 mM tris-HCl, pH 7.4, with 1 mM EDTA, 0.0125% DSS 
and >98% D2O that were used in the carbon-edited TOCSY and NOESY experiments.   
To verify the stability of the samples, 2D 1H-15N HSQC or 2D 1H-13C HSQC spectra 
were run between every other triple-resonance experiment used for assignments. We 
ran the following standard suite of gradient-based heteronuclear triple resonance 3D 
spectra for backbone assignments: (HNCO, HN(CA)CO, HNCACB, CBCA(CO)NH).13-16 
Further, 15N-NOESY-HSQC, 15N-TOCSY-HSQC, 13C-HCCH-TOCSY, CC(CO)NH, and 
13C-NOESY-HSQC13,17,24 experiments were utilized to obtain side-chain resonance and 
proton assignments.17 Spectra were processed with NMRPipe18 and analyzed in 
Sparky.19   
3.4.3. Extent of Assignments and Data Deposition 
The datasets enabled assignments of ~95% of the HN, N, Cα, Cβ, C′and carbon 
side-chain assignments of MLDVvDUF5, including 96% of the backbone resonances. We 
have used the same naming convention as the crystal structure (PDB 4ERR). The 
assignments are deposited in the BMRB under accession number 18562. The 1H-15N 
gradient HSQC spectrum (Figure 3.3, left) demonstrated good resolution and 
dispersion. We did not observe amide 1H-15N correlations in the HSQC for the following 
residues: Q3, F17, R41, T63, G65, R66, and Q68. Of the backbone amides signals 
observed, all but one were assigned; the missing assignment likely arose from the C-
terminal His6-tag. In most cases, we were able to assign the CA, CB, and C’ of the 
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residues missing amide frequencies in the HSQC using CBCA(CO)NH and HNCO 
experiments. C(CO)NH and 13C-edited HSQC-TOCSY experiments enabled us to 
assign the 13C side-chain resonances. In these experiments, we observe significant 
degeneracy in many of the aliphatic residues for the CD of L residues (L29, L32, L34, 
L50, L70, L73, L81, and L83), as well as the CG in V16.  
TALOS+20 analysis demonstrated four helices, consistent with those observed in the 
homology model of MLDVvDUF5, based on structure prediction from the crystal structure 
of PMT (Figure 3.3, right). The helices consist of residues H1 (residues 7-15), H2 
(residues 23-36), H3 (residues 40-61), and H4 (residues 67-81), with intervening loop 
residues L1 (residues 16-22), L2 (residues 37-39), and L3 (residues 62-66). The 
missing assignments of non-P amide resonances belong to the N-terminal methionine, 
the C-terminal His6-tag, a single residue in the first turn of helix H3 (R41), residues in 
loop L1 (F17) and loop L3 (T63, G65), and the first turn of helix H4 (R66, Q68). This 
suggests amide exchange in these regions, which indicates an exposure to solution, as 
would be expected in loop regions or solvent exposed helices.  
According to structure prediction, loops L1 and L3 are adjacent to each other at the 
same end of the 4HB. Broadening is observed throughout these regions, which is 
presumably due to chemical exchange and may be related to the mechanism of 
membrane association.11 Resonance assignments provide a basis for solving the 
structure of the isolated MLDVvDUF5 and understanding the conformation and dynamics 
of membrane association.  
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3.5. Extent of the Assignments of the Micelle Bound State of MLDVvDUF5 
3.5.1. Biological Context of the Micelle State 
  As stated in chapter 3.4.1, MLDs target anionic phospholipids at the inner leaflet of 
the cell. In the case of MLDVvDUF5, it is assumed that the target of the DUF5 domain is at 
the plasma membrane. We hypothesize that membrane targeting may require a 
conformational change, such as the one observed in 4ERR that shows an extended 
dimer. Thus, the backbone assignments and calculated dihedral angles are important 
initial steps towards determining the topology of the membrane associated-state and 
towards understanding the physiological relevance of the crystal structure 4ERR (Figure 
3.4). 
	  
	  
Figure 3.3.  Solution assignments and secondary structure of MLDVvDUF5. (Left) 1H -15N 
2D HSQC spectrum of MLDVvDUF5 acquired at 600 MHz (1H frequency) at pH 6.0. Of 77 
expected amide resonances 70 are observed and assigned. (Right) Secondary 
structure elements of the MLDVvDUF5 identified by TALOS+ compared to the secondary 
structure from the homology model generated from the crystal structure of the MLD 
from the C1 domain of PMT.2,21  Plotted are the Phi (Φ) (black circles) and Psi (Ψ) (gray 
squares) backbone torsion angles as predicted by TALOS+.20 Along the x-axis is a 
cartoon representation of the secondary structure based on the crystal structure [2EBF 
(green)8] and the secondary structure predicted by TALOS+ (red). The residue 
numbers from the construct are listed along the x-axis. 	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 3.5.2. Methods and Experiments 
 Proteins were expressed and purified as discussed in chapter 3.4.2. A sample 
containing 1 mM MLDVvDUF5 bound to LMPG micelles was prepared in one of two ways, 
yielding similar spectra: 1) Dilution of the 60 mg/mL MLDVvDUF5 to 10 mg/mL in 20 mM 
tris-HCl, pH 7.4 buffer, containing 3.75 mM EDTA, 0.0125% DSS, and 12.0% D2O in a 
final volume of 500 µL, followed by addition of 36 mg of powdered LMPG; or 2) Addition 
of 43 µL of stock MLDVvDUF5 solution to 18 mg of LMPG, followed by dilution with 414 µL 
of 20 mM tris-HCl, pH 7.4 buffer, containing 3.75 mM EDTA, 0.0125% DSS, and 12.0% 
D2O. This resulted in a final solution of 1 mM MLDVvDUF5 (10 mg/mL) and 150 mM 
LMPG for the first method, and a solution of 0.5 mM MLDVvDUF5 (5 mg/mL) and 75 mM 
LMPG for the second method. The 1H-15N HSQC spectra exhibited a similar fingerprint, 
indicating that there was no significant perturbation to the structure of MLDVvDUF5 with 
changes in protein concentration and that an equilibrium micelle-bound state could be 
reached regardless of the order of addition. We used the following experiments to 
perform backbone assignments: HNCA, HNCO, HN(CA)CO, HN(CO)CA, HNCACB, 
CBCA(CO)NH, and CCONH 3D experiments, as well as the corresponding 2D 
experiments. All spectra of MLDVvDUF5 in the presence of LMPG micelles were acquired 
at 40ºC. 
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 3.5.3. Extent of Assignments 
Linewidths for the MLDVvDUF5 are approximately 50% greater than that observed in 
the solution state. The dispersion of the peaks in the MLDVvDUF5 HSQC spectrum 
(Figure 3.5, left) was sufficient to perform assignments to a similar extent as the micelle-
free state.  Some residues were assigned for the micelle-bound state that were 
unassigned in the micelle-free state (F17, R41, G65).  For the micelle-bound state, a 
total of 73 (out of 77 expected) amides could be assigned; only Q3, S64, R66, and Q68 
remain unassigned. We assigned most of the heavy atoms (92.0%) and most of the 
backbone chain (95.8%), with nearly all of the missing backbone atoms occurring in 
loop L3. Most of the missing side-chain heavy atoms were either CD or CE atoms in R, 
K, and I residues or were next to the three Ps and unable to be assigned through the 
CCONH TOCSY.  
	  
	  
Figure 3.4:  Crystal structure (PDB entry 4ERR) reveals MLDVvDUF5 as an extended 
dimer. There appears to be a hydrophobic interface between the dimers (aliphatic 
side-chains in grey) 	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Secondary structure analysis by TALOS+ indicated that the 8 residues that comprise 
loop L1 in the solution state convert to a helical conformation when bound to the micelle 
(Figure 3.5, right). Loops L2 and L3 appear to have minor differences in the geometry 
and no change in the residues that putatively make up these loop regions. This result is 
consistent with the extended conformation observed in the crystal structure 4ERR.   
This data confirms that there is a significant change in the geometry and conformation 
of the MLDVvDUF5 in the presence of membranes that needs to be further explored via a 
variety of experiments discussed in chapter 5.  
 
	  
	  
Figure 3.5.  Micelle assignments and secondary structure of MLDVvDUF5. (Left) 1H -
15N 2D HSQC spectrum of MLDVvDUF5 bound to LMPG micelles (150 mM LMPG: 1 
mM MLDVvDUF5) acquired at 600 MHz (1H frequency) at pH 7.4. Of the 77 expected 
core amide resonances 73 are observed and assigned. (Right) Secondary structure 
elements of the micelle bound MLDVvDUF5 identified by TALOS+ compared to the 
TALOS+ results from the solution NMR structure of the MLDVvDUF5.20 Plotted are the 
Phi (Φ) (black circles) and Psi (Ψ) (gray squares) backbone torsion angles as 
predicted by TALOS+.21 Along the x-axis is a cartoon representation of the 
secondary structure based on the solution NMR structure [Solution (red)] and the 
secondary structure predicted by TALOS+ for the micelle bound state (orange). The 
residue numbers from the construct are listed along the x-axis. 	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CHAPTER 4 
Structure and Dynamics of the Membrane Localization Domain of 
Pasteurella multocida Toxin Reveal a Key pH-Dependent Salt-Bridge 
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4.2. Abstract 
 We used NMR and liposome pulldown assays to interrogate the solution structure 
and dynamics of the MLD of PMT at cytosolic and endosomal pH and to assess how pH 
impacts binding of the MLD to anionic phospholipids. The solution structure is a 4HB, in 
which two salt bridges involving residues H35 and H48 stabilize the helix packing in a 
pH-dependent manner. Only H48 changes protonation states between cytosolic and 
endosomal pH. Upon deprotonation of H48, loop L3 becomes significantly more 
dynamic. This enables the MLD to adopt a second conformation, which appears to be 
important for binding to the membrane. This secondary conformation has an extended 
helix H1 as observed in the TALOS+ angles derived from assignments of the micelle-
bound state, suggesting that a conformational selection occurs upon membrane 
binding. 
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4.3. Introduction    
 The MLD of PMT (MLDPMT) has been shown to be important for optimal targeting of 
the C3 deamidase domain to the plasma membrane when exogenously expressed in 
mammalian cells4,5, similar to that observed in other MLDs.1,2,3 A C-terminal fragment 
containing C1-C2-C3 and the MLD alone bind anionic phospholipids in lipid pulldown 
and SPR assays.4 Kamitani et al. also demonstrated that all four helices in the MLD 
were important for targeting the transfected protein to the inner leaflet of the membrane, 
which is enriched in the anionic phospholipids phosphatidyl serine and phosphatidyl 
inositol.6  
 The structure of the 4HB within the C1 domain of the C1-C3 domains of PMT has 
been confirmed by X-ray crystallography for PMT (PDB 2EBF)5, and for the MLD in 
conjunction with its adjacent effector domain for 3 other MLD-effector domains found in 
the clostridial toxins TcsL (PDB 2VL8)7, TcdA (PDB 3SS1)8, and TcdB (PDB 2BVL).9 In 
contrast to these structures in the context of other effector domains, the one structure 
available of an MLD in isolation from its adjacent effector domains shows an extended 
dimeric complex (PDB 4ERR). Noteworthy, however, is the observation that the crystal 
only formed in the presence of 1,2-dihexanoyl-sn-glycero-3-phospho-L-serine 
phospholipids. Thus, it is necessary in order to delineate the mechanism by which the 
MLD interacts with anionic phospholipids to solve the structure of the MLD in the 
solution state and to verify that the 4HB in isolation is in fact the same 4HB observed in 
the crystal structures. This would support that the crystal structure of the extended state 
(PDB 4ERR) is selected for in the presence of the membrane and is not an artifact 
derived from isolating the 4HB. 
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 From liposome pulldown assays we know that other MLDs bind to anionic 
phopsholipids and not zwitterionic phospholipids8,9; however, this has not been shown 
conclusively for MLDPMT using this assay. Liposome pulldown assays have implicated 
electrostatic interactions as being important for proper binding; mutation of lysine and 
arginines in loops L1 and L3 for other MLDs result in significantly reduced binding and 
pulldown. It is hypothesized that these electrostatic interactions are necessary to 
facilitate membrane insertion of a key hydrophobic residue in loop L1 (in the case of 
MLDPMT, residue I16).2 There are other potential mechanisms, including one that would 
explain the arrangement observed in 4ERR; the hydrophobic interface that forms as the 
dimerization interface may in fact interact with the membrane.  
 Thus, it is necessary to acquire atomic-resolution data to delineate between the 
multiple mechanisms that could be resulting in membrane binding, as well as the 
subsequent topology. We also want to utilize the capability of NMR to examine fast limit 
dynamics at the nanosecond/picosecond level (R1, R2, NOE)10, as well as 
microsecond/millisecond dynamics that are more important for conformation selection 
that may be important for binding (R1ρ, R2ρ, T2 CPMG).11  
 For our studies, we decided to use micelles to investigate how MLDPMT interacts with 
membranes in our NMR studies. Micelles can be used to simulate a lipid environment 
and allow for simple and repeatable sample preparation due to their self-assembly 
property. By using short-chained lysophospholipids such as LMPG, which is used often 
in solution NMR due to the low molecular weight (~25 kDa) micelles it forms4, we can 
rapidly screen detergent concentration and pH to assess NMR conditions for 
assignment using 15N-HSQC experiments while also determining whether the bound 
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state is uniform or has multiple conformers. This is complemented by data from the 
liposome pulldown assay that assesses whether the protein is binding to the lipid in a 
timeframe that would enable co-precipitation.  
 Thus, we have solved the solution NMR structure of MLDPMT, assigned the micelle-
bound state, and assessed dynamics to provide insight into the mechanism of MLD 
binding to anionic phospholipids, while verifying our results through use of in vitro 
assays. We utilize a combination of biophysical assays and NMR of the solution state 
and the micelle-bound state under conditions mimicking the cytosol and endosome to 
understand the physiological conditions that promote membrane binding. 
 We further study the effect that pH has on the structural integrity and membrane 
binding of the MLDPMT, since most of the MLDs studied so far via liposome pulldown 
assays are from MARTX toxins and move directly from the extracellular matrix to the 
cytosol without undergoing pH changes. We have observed changes only in the 
chemical shifts of protons and carbons within H side-chains and not D or E side-chains. 
This suggests that only the protonation state of some H is changing between pH 6.0 
and 7.5, and thus any change in dynamics is likely due to changes in the putative H-E 
salt bridges.  
4.4. Experimental Procedures 
Recombinant protein expression and purification- The MLDPMT protein was expressed 
and purified as discussed in chapter 3.2.2.13 
 
NMR Data Collection. Solution NMR spectra were acquired at the School of Chemical 
Sciences NMR Facility (University of Illinois at Urbana-Champaign) on a Varian INOVA 
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600 spectrometer equipped with a 5-mm, triple resonance (1H-13C-15N) triaxial gradient 
probe, using VNMRJ version 2.3 with the BioPack suite of pulse programs. Spectra 
used to assign the spectra were acquired at 30°C on U-13C, 15N samples at 1 mM in 20 
mM bis-tris buffer, pH 6.0, with 100 mM NaCl, 0.01% DSS and 10% D2O (v/v), as 
described previously.13 Additional data sets collected for the structure determination 
included: (1) Long-range distant restraints assigned from 99% D2O back-exchanged 
samples using 13C-HSQC-NOESY experiments for the aliphatic region for 29 hours and 
digitized to 55 Hz in the proton and 190 Hz in the carbon dimensions and for the 
aromatic regions for 17 hours and digitized to 60 Hz in the proton and 150 Hz in the 
carbon dimensions (calculated by VNMRJ, version 2.2, (Digitization = 1/(dwell time*# of 
increments))); (2) Long-range distance restraints assigned from the 15N-HSQC-NOESY 
experiment acquired for 13 hours and digitized to 85 Hz in the proton and 70 Hz in the 
nitrogen dimensions using a 10% D2O:90% H2O sample (calculated by VNMRJ, version 
2.2). (3) J-coupling measurements determined from the HNHA experiment, in which a 
15N labeled sample in 10% D2O, 90% H2O was used to acquire the spectrum for 22 
hours and digitized to 70 Hz in the proton and 35 Hz in the nitrogen dimensions 
(calculated by VNMRJ, version 2.2)). 
 
Data Analysis and Structure Calculations. Spectra were processed with NMRPipe14 and 
analyzed in Sparky.15 Dihedral angles were predicted from the backbone chemical shifts 
using TALOS+.16 The phi angle was also empirically determined from the HNHA 
experiment, as described previously.16 NOESY peaks (data height and peak position) 
from carbon and nitrogen edited 3D experiments were imported into the PASD 
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algorithm using data height as an indicator of overall intensity, to make initial 
assignments and to assign distance bins. TALOS+ dihedral angles17 were included in 
the PASD calculations within XPLOR-NIH.18 Additional ambiguous peaks were manually 
assigned from intermediate structures. J-coupling measurements were included in the 
refine.py script with standard values for A, B, and C to convert coupling constants 
determined from the signal intensities in the HNHA experiment into angles (A= 6.98, B=-
1.38, C=1.72, phase=-60.0). Refinements to the structure were made until the top ten 
percent of structures had fewer than 2 violations. Putative salt bridges were first 
observed in the NMR ensemble structure from NOE distance restraints. We added in 
additional NOE restraints between nitrogen and oxygen side-chain atoms (3.5 +/- 0.5 Å) 
to model the putative salt-bridge and the structure was re-calculated to make sure no 
new violations were introduced. RMSD calculations were made using VMD19 for both 
backbone residues, as well as for all heavy atoms for the top ten structures. 
Ramachandran Analysis was made using the PSVS server to verify angular geometry.20 
 
Titration Experiments. A volume of 500 µL of 1 mM MLDPMT sample in 2 mM bis-tris 
buffer, pH 6.0, containing 100 mM NaCl, 3 mM EDTA, and 0.01% DSS (prepared as 
discussed in detail in chapter 3.2.2 and 3.2.3) was diluted with 50 µL of 500 mM Tris-
HCl/bis-tris solution, buffered at either pH 6.0, 6.5, 7.0, 7.5, or 8.0 to adjust pH of the 
sample to the new pH to yield a final concentration of 45 mM tris plus 45 mM bis-tris. In 
the case of the pH 5.0 sample, a final concentration of 90 mM acetic acid buffered to pH 
5.0 was used instead of the tris/bis-tris buffer.15N-HSQC, HCACO modified to observe 
side-chain carbonyls, and aromatic 13C-HMQC spectra were acquired at 30°C for the pH 
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values of 6.0, 6.5, 7.0, and 7.5 for the solution-state MLDPMT samples without LMPG. 
  
LMPG Titration Experiments. Samples from the solution titration experiments were 
taken and dry powdered LMPG (how much?) was added and mixed until the LMPG was 
fully dissolved. To increase the global correlation time and T2 relaxation time constant, 
the temperature was raised to 40°C for the 15N-HSQC spectra acquired for samples at 
pH 5.0, 6.0, 6.5, 7.0, or 7.5 at LMPG concentrations of 12.5, 25, 50, or 100 mM. Higher 
concentrations (150 mM) of LMPG did not further perturb the spectra at pH 7.0 or 6.0 
and are thus not shown in the titration experiments. 
 
Dynamics Measurements. T1 and T2 measurements were performed using a modified 
HSQC experiment at 600 MHz using a modified gradient HSQC measurement. T1 and 
T2 were measured through acquiring the HSQC with 180° proton pulses every 5 ms (T1) 
or with 180° proton pulses every 5 ms and 15N refocusing pulses every 625 µs (T2) and 
then fitting the intensity decay curves in Sparky.15 NOE measurements were made 
using a pulse delay of 10 s, as described previously.21 From NOE, T1, and T2 values, 
order parameters were calculated from Lipari-Szabo using FASTModelfree software 
package22 and the correlation times were calculated using TmEst.23  
Rex measurements were made using a CPMG pulse-train.33 We measured the 
pulsing rates as fast as 1.7/ms and as slow as 0.1/ms to determine the kex values for 
each, and thus the Rex from the difference in the kex. We used the 2ptrate software 
(http://www.profs.inrs.ca/ndoucet/links.html) to calculate Rex values and plotted them as 
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a function of residue. Rex rates were within error 0, and did not change upon decreasing 
of the temperature to 10°C.  
 
 
Backbone Assignment of the Micelle Bound state of MLDPMT. A U-13C-15N sample of 1 
mM MLDPMT containing 150 mM LMPG at pH 7.0 was used for backbone assignments. 
A standard suite of 3D experiments were acquired at 40°C, including HNCA, HNCACB, 
HNCO, HN(CA)CO, HN(CO)CA, CBCA(CO)NH, and CCONH spectra. TALOS+17 was 
used to determine secondary structure characteristics from the chemical shifts. 
 
Chemical Shift Perturbation Analysis-Analysis was performed in Sparky. Overlaid 
spectra of different MLDPMT at different pHs in the solution state allowed for peak 
assignments to be followed during the titration. Final chemical shift positions were 
verified using the 15N-HSQC-TOCSY 3D experiment, as minimal perturbation was 
observed in the HA and HB resonances between pH 6.0 and pH 7.5. The overall 
movement was quantified as δ, which is defined by the following equation:   𝛿 = ( 0.1 ∗ 𝛿𝛥! ! + 𝛿𝛥! !) 
where the term δΔ represents the chemical shift perturbation between pH 6.0 and pH 
8.0.24 Residue-specific perturbations are viewed either as a bar-graph or are rendered 
by attribute in Chimera25 for the solution-state and for the micelle-bound state with and 
without the His6-tag.  
 
T1ρ and T2ρ measurements. Measurements of T1ρ and T2ρ were acquired on an 
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Agilent 750 MHz spectrometer with a 5 mm Varian 1H{13C/15N} PFG X,Y,Z probe. We 
used the pulse sequence developed by the Veglia group.11 In short, a series of adiabatic 
full passage pulses were used to obtain relaxation rates, where increasing the number 
of adiabatic pulses in the train resulted in increasing the relaxation time (similar to 
pulse-trains used in T1 and T2 measurements). The relaxation rate was fit using Sparky 
for each of the 5 different stretching factors, thus varying the time spent at any of the 
frequency offsets, which allows for residue-specific dispersion of relaxation rates. The 
maximum and minimum values calculated from each residue were determined and 
subtracted. For those residues showing significant dispersion, the individual curves 
were plotted to ensure that they represented an actual dispersion curve with an 
asymptote and not just random noise. Experiments were acquired at 10°C for both pH 
6.0 and pH 7.5 samples to observe maximum dispersion. 
 
Liposome Preparation. Briefly, liposome mixtures containing natural abundance tail-
groups were re-constituted from chloroform stocks into polypropylene microfuge tubes. 
PC/PE/CHL liposomes were comprised of 11 mg phosphatidyl choline from egg (Egg 
PC), 6.6 mg trans-phosphatidyl ethanolamine (trans-PE: head-group modified to PE 
from PC), and 2.4 mg cholesterol (from 10 mg/mL chloroform stock). PC/PG/PE/CHL 
liposomes were comprised of 4.4 mg Egg PC, 6.6 mg trans-PE, 6.6 mg 
phosphatidylglycerol from egg (Egg PG) and 2.4 mg cholesterol (from 10 mg/mL 
chloroform stock). The chloroform mixtures were dried under nitrogen gas until a film 
was observed and then placed under speed-vacuum for one hour with a dry-ice bath 
trap. The lipids were re-suspended in a volume of 1 mL of 20 mM Hepes buffer, pH 7.4, 
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with 100 mM KCl buffer to a concentration of 20 mg/mL. The lipid mixture then 
underwent 5x freeze-thaw cycles using freezing in liquid nitrogen and thawing in a 
warm-bath at 37°C to generate multi-lamellar vesicles. These lipids were then extruded 
11 times through a 1.0-µm pore-sized, followed by a 0.2-µm pore-sized membrane 
using the Avanti Polar Lipids Extruder at room temperature, according to manufacturer's 
protocol.  
 
Liposome Pulldown Assay. The assay was performed similarly to those described 
previously.2 The sample preparation for the liposome pulldown assay was performed at 
room temperature. First, MLDPMT was diluted into sterile water from an initial protein 
concentration of 20 mg/mL and an initial salt concentration of 500 mM NaCl at pH 6.0, 
to a final protein concentration of 150 µg/mL and a salt concentration of ~3.75 mM 
NaCl. Samples (250 µL each) were prepared through serial additions followed by mixing 
via pipetting of: 1) 25 µL of 20 mg/mL lipid solution, containing either PC/PE/CHL or 
PC/PG/PE/CHL in 20 mM Hepes, pH 7.4 buffer with 100 mM KCl, prepared as above in 
the previous section; 2) 10 µL of 500 mM tris plus 500 mM bis-tris, buffered at the 
desired pH of 6.0, 6.5, 7.0, or 7.5; 3) 50 µL of a solution of 150 µg/mL MLDPMT; 4) 40 µL 
of 0.25 M KCl; 5) 125 µL of 2 mM MgCl2 and 2 mM CaCl2. This resulted in a solution 
with final concentrations of 30 µg/mL protein, 2 mg/mL liposomes 20 mM of tris/bis-tris 
buffer with 50 mM KCl, 1 mM MgCl2 and 1 mM CaCl2 at the desired pH value of 7.5, 
7.0, 6.5, or 6.0. Samples were then incubated in water bath at 37°C for 5 min before 
transferring 200 µL to a 250 µL ultracentrifuge tube (Beckman) and then subjecting to 
ultracentrifugation at ~170,000 rcf in a TLA-100 rotor for 2 hours at 4°C (66,000 rpm). A 
	   	   	   	   	   	  105	  
180-µL aliquot of the supernatant was removed and diluted by with 45 µL of 6X SDS-
PAGE sample buffer (prepared as a stock solution by mixing 5 mL β-mercaptoethanol, 5 
g sodium dodecyl-sulfate, 25 mL glycerol, 30 mg bromophenol blue, and 18.75 mL of 1 
M tris-HCl buffer, pH 6.8, in a total volume of 50 mL and filtering through a 0.22 micron 
membrane). The remaining liquid was first removed via aspiration using a pipette tip. 
The pellet was then re-suspended into a volume of 240 µL of 20 mM Hepes, pH 7.4 
buffer, with 100 mM KCl and mixed with 40µL of 6X SDS-PAGE buffer. Proteins were 
separated by 16% tris-tricine gel electrophoresis run at 40 milliamps and constant 
current for 2 hours. Gels were fixed for 30 min with a solution of 40% methanol, 20% 
acetic acid, and 40% water at room temperature on a shaker and then stained with 10 
mL of Coomassie blue stain solution (prepared as a stock solution by mixing 0.29 g G-
250 Coomassie day in 100 mL acetic acid plus 900 mL water). The gel was then de-
stained with 10% acetic acid in the presence of a Kimwipe at room temperature for 30-
minute intervals (replacing the Kimwipe every 30 minutes) until the desired level of 
staining contrast was achieved. The gels were then photographed using an IPhone5 
and the images were cropped and imported into ImageJ. Densitometry of the stained 
protein bands was measured by using ImageJ. The average intensity was multiplied by 
the size of the band to determine the total value, and was subtracted from baseline 
intensities of the gel taken directly above the band. These values were converted into 
absolute intensity in Excel ((Avg Intensity Band-Avg Intensity Blank)*Band Area) and 
the percentages of the proteins in the supernatant versus pellet samples for each trial 
were determined and evaluated, using the following equation, (Intensity Pellet/(Intensity 
Supernatant + Intensity Pellet)). The standard deviation was derived from 3 trials. 
	   	   	   	   	   	  106	  
4.5. Results 
 
 
 
 
 
 
 
 
 
 
Structure of MLDPMT in solution reveals Four-Helical Bundle. To understand the 
mechanism of binding, we first wanted to verify the structure of the isolated MLD 
separate from the rest of the C1-C2-C3 domains that are present in the crystal structure 
(PDB ID: 2EBF). The MLDPMT was solved to a bbRMSD of 0.46 Å (heavy atom RMSD 
of 1.05 Å) (Table 1) at pH 6.0 in 100 mM NaCl, where the greatest deviations occurred 
in the N-terminal region, as well as loop L2 (Figure 4.1A), due to the relative lack of 
NOE restraints for both the N-terminal residues and loop L2 residues.   
 The 4.9 long-range NOE restraints per residue provided sufficient restraints, in 
conjunction with the 80 well-defined TALOS+ angles and the complementary 69 
dihedral angles from measuring the J-coupling using the HNHA experiment. As 
 
Figure 4.1.  Structure of MLDPMT solved via solution NMR. Overlay of the ten 
lowest-energy structures (A) from Table 1 illustrates the bbRMSD of 0.46 Å for 
our ensemble of structures (heavy atom 1.05 Å). The helices are individually 
colored (H1=lightest blue, H4=darkest blue). (B) The four-helical bundle from the 
1.9Å crystal structure 2EBF (H1=pink, H4=red). (C) Comparison of the average 
NMR structure (A) to the crystal structure (B) yields 1.94 Å bbRMSD (2.53 Å 
heavy atom RMSD). 
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expected, most long-range contacts occurred between adjacent helices (H1 to H2 or 
H4, H3 to H2 or H4), but multiple H2-H4 contacts were observed between aliphatic side-
chains. This is in good agreement with what is observed in the crystal structure (Figure 
4.1B), including the relative helix orientations; however, the side-chain conformations 
differ between the NMR structure and the crystal structure 2EBF.  
 The main difference between the 4HB observed in the crystal structure of 2EBF, 
which was solved at pH 6.5 in 1.6 M ammonium phosphate plus 0.1 M MES buffer, and 
the NMR structure of the MLDPMT, solved at pH 6.0 in 20 mM tris-HCl with 100 mM 
NaCl, is in the tilt of helix H1 and subsequent arrangement of loop L1 (Figure 4.1C).  
 pH titration of MLDPMT reveals significant perturbations around H48. Changing the pH 
from 6.0 to 8.0 revealed perturbations in many of the amide residue chemical shifts. 
Some residues such as W4 (Figure 4.2B) were unperturbed, while others had small 
perturbations (residue E52, Figure 4.2C), others lost intensity (residue L40, Figure 
4.2B), and others shifted position while losing intensity (residue I16, Figure 4.2B). All of 
the amide chemical shifts for the H residues (residue H86: Figure 4.2A, residues H35 
and H48: Figure 4.2C), showed at least some perturbation with the greatest perturbation 
observed for residue H86 (δΔ of 0.39 compared to 0.05 for residues H35 and 0.08 for 
H48).  
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 Protein 
NMR distance and dihedral constraints  
Distance constraints  
    Total NOE 2411 
    Intra-residue 1075 
    Inter-residue 1336 
      Sequential (|i – j| = 1) 411 
      Medium-range (|i – j| < 4) 541 
      Long-range (|i – j| > 5) 384 
Total dihedral angle restraints  
    φ  (TALOS+) 80 
    φ (J-Coupling) 
    ψ (TALOS+) 
   
69 
80 
  
Structure statistics for top 20 
structures 
 
Violations (mean and s.d.) 1.2 +/- 1.0 
    Distance constraints (Å)     0.8 +/- 0.6 
    Dihedral angle constraints (º) 0.1 +/- 0.3 
    Max. dihedral angle violation (º)     7.71 
    Max. distance constraint violation (Å)  0.61 
Deviations from idealized geometry 0.3 
    Bond lengths (Å)     0 
    Bond angles (º) 0 
    Impropers (º) 
    Van der Waals Radius 
    Max Van der Waals violation 
0 
0.3 +/- 0.5 
0.26 
 
Average pairwise r.m.s. deviation** (Å)      
    Heavy      1.05 
    Backbone   0.45 
  
  
   
 
Table 4.1.  Table of parameters for the solved structure of MLDPMT. Statistics were 
collected for the top 10 out of 100 structures as solved using XPLOR-NIH. NOE 
assignments were initially made using the PASD algorithm, and then assignments 
were filled manually. 
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  The biggest perturbations occurred for residues near residue H48 (residues G45, 
L46, M47, and E49), as well as around loop 3 (residues E58, E59, S64, L67, and R71), 
and the solvent-exposed face of helix 4 (residues E72, T75, and K79), with smaller 
perturbations appearing in and around loop 1 (residues S14, I16, G21, Y24, and K25). 
However, while the amide chemical shift had a significant perturbation for residue H35, 
the protons on the aromatic carbons had a significantly smaller perturbation (~5-fold) 
compared to residue H48 and the His residues belonging to the His6-tag (for residue 
H35, δΔ of 0.03 for atom HD2 and 0.09 for atom HE1; for residue H48, δΔ > 0.17 for 
atom HD2 and > 0.37 for atom HE1). 
 We did not observe perturbations in the side chains of Asp or Glu residues as a 
function of pH, as would be expected in the case of ionization or conformational 
changes of these residues. This strongly suggests that any differences in conformation 
or dynamics observed between pH 6.0 and pH 7.5 are likely due to H48.  
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Figure 4.2.  NMR chemical shift perturbations of MLDPMT as a function of pH. (A-C) 
Titration from pH 6.0 to 8.0 of MLDPMT in solution reveals chemical shift perturbations 
and intensity modulations for three different regions of the spectra, (A) including for 
H86 (C) and for H35 and H48, as expected. (B) Other residues show no variation in 
position or intensity (W4, B). Final positions were verified using a 15N-HSQC-TOCSY 
experiment. The chemical shift perturbation, δ, is calculated as in the equation 
where δΔ represents the chemical shift perturbation 
between pH 6.0 and pH 8.0. Those that have greater perturbation than 0.05 ppm are 
labeled in the bar graph. (D) Looking at δ as a function of residue suggests that the 
main perturbations occur around residue H48 (H3: G45, L46, M47, H48, E49, M51 
H4: T75, K79), in loop L1, and in the residues surrounding loop L3 (Y57, E58, E59, 
S64, L67) as observed via a bar chart. (E) This trend is more obvious when mapping 
the perturbations onto the structure, where red indicates significant perturbations 
(>0.04 ppm). 
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Dynamics measurements reveal increased motions at cytosolic pH. To investigate the 
dynamics of the solution-state MLDPMT at pH 7.5 versus pH 6.0, we measured multiple 
relaxation parameters including R1, R2, and NOE and the order parameter as a function 
of pH. While NOE and S2 showed no significant change and R1 had a systemically 
slightly lower value at pH 7.5, R2 showed a significant increase in L3 residues at pH 7.5 
(Figure 4.8). This leads to a slightly longer correlation time at pH 7.5 (6.7 +/- 0.9 ms), as 
compared to pH 6.0 (6.3 +/- 0.7 ms), which is corroborated by the hydrodynamic radius 
increasing from 13.3 Å at pH 6.0 to 15.3 Å to pH 7.5. This would suggest an extended 
conformation as observed in the crystal structure of MLDVvDUF5 (PDB ID: 4ERR). This is 
further supported by the significant increase in the exchange rate (Kex) in loop L3 
(Figure 4.8) and a slight increase in loop L1; however no significant Rex (>1) is observed 
for any of the residues at 30°C, 20°C, or 10°C. 
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Figure 4.3.  Exchange dynamics of MLDPMT. (A) Measurement of R1ρ and (C) R2ρ 
for MLDPMT at 10°C at either pH 6.0 (red) or pH 7.5 (black) using a series of 
adiabatic pulses. (B) Residues with a R1ρ exchange greater than 5 at pH 7.5 
compared to the control residue of I39 or W4 are found either at the edge of loop L3 
(E58 (6.3 s-1), Q61 (6.2 s-1), R66 (5.0 s-1), L67 (5.8 s-1)) or in L1 (V15 (5.0 s-1), I16 
(6.4 s-1), G21 (5.7 s-1) as illustrated. (C) R2ρ values for residues that show R2ρ 
exchange greater than 4 s-1 normalized to that of I39 and cross-checked by 
normalization to that of W4 (grey). (D) Residues that show significant R1ρ and R2ρ 
rates are E58 (7.1 s-1), R66 (7.3 s-1), and L67 (6.4 s-1) while residues that only show 
significant R2ρ rates are E59 (4.8 s-1), S60 (5.0 s-1), and S63 (4.0 s-1). These 
residues have their side-chains drawn and surround a putative E58-R66 salt-bridge 
that we believe is important for maintaining the integrity of the 4HB. 
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T1ρ and T2ρ measurements reveal increased dynamics at cytosolic pH in loop regions. 
The increase in Kex measurements suggested that conformational dynamics could be 
occurring at a faster rate than can be measured through a traditional CPMG 
experiment.11 Recently, an improved method for determining regime exchange was 
developed and validated with studies of the well-characterized protein ubiquitin.11 In 
particular, residues in ubiquitin that did not reveal dynamics using the CPMG pulse 
sequence did using the adiabatic pulse train. 
 Measurement of T1ρ (Figure 4.3A) revealed significant increases in microsecond 
motions in loops L1, L2, and L3. The increase in microsecond motions is likely a 
consequence of interchange between the 4HB and a second conformation, with the 
greatest differences at pH 6.0 and pH 7.5 being observed in loops L2 and L3; in 
particular we observe increased dynamics for residues N38 and L40 in loop L2, and in 
residues S60, S63, R66, L67 in loop L3 (Figure 4.3B). Other residues that had elevated 
dynamics in T1ρ were residues V15, I16, and G21 (Figure 4.3B) in loop L1, and 
residues Y57, E58, E59, N68 and A69 in loop L3. 
 Measurement of T2ρ (Figure 4.3C) revealed significant increases in millisecond 
motions at pH 6.0 and to an even greater extent at pH 7.5. In particular, residues E58 
and R66 are increased by over 50% at pH 7.5, while the surrounding serines (S60 and 
S63) and residue E59 show ~25% increases in the dynamics. Residues E58, R66, S60, 
S63, E59 and L67 exhibited significantly elevated exchange rates (Figure 4.3D) that 
suggest that the loop L3 is dynamic. 
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Binding of MLDPMT to anionic micelles reveals a single conformation only at cytosolic 
pH. To correlate the observed dynamics to the functional activity of MLDs, which is 
binding to bilayers containing anionic phospholipids, we acquired HSQC spectra of 
MLDPMT as both a function of pH (ranging from 5.0 to 8.0) and as a function of LMPG 
concentration (ranging from 12.5 mM to 100 mM). We observed, significant 
perturbations to the amide chemical shifts between no LMPG and 12.5 mM LMPG, and 
 
Figure 4.4.  HSQC of MLDPMT at endosomal and cytosolic pH in the presence of 
LMPG micelles. pH titration of the MLDPMT from cytosolic conditions (pH 7.5) to late 
endosome (pH 6.0) suggest that the 4HB changes significantly at conditions 
approximating the late endosome. Loss of peaks between HSQC of the MLDPMT at 
pH 6.0 (A) to pH 7.5 (B) as observed in the overlay (C) imply that the 4HB is more 
rigid at pH 6.0 and is supported by dynamics measurements (Figure 4.10). Binding 
of the MLDPMT to a LMPG micelle (D-F) appears to generate a single conformation 
with resolved peaks only at or above pH 7.0 (E) and not at pH 6.0 (D), with the 
overlay (F) demonstrating the elimination of broad linewidths. This suggests that the 
MLDPMT functions as a membrane localization domain in the cytosol as hypothesized 
previously. Cleavage of the His-tag reveals a similar pattern. 
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less significant perturbations upon increasing LMPG concentrations up to 50 mM. 
Additional LMPG causes diminishingly small perturbations in chemical shifts. 
 Comparing the solution spectra at pH 6.0 and pH 7.5 without LMPG, we observed a 
significant intensity loss in most residues at pH 7.5; however, at 100 mM LMPG, we 
observed an better resolved spectrum at cytosolic pH despite the resolved peaks having 
similar signal to noise in the micelle bound spectra at pH 6.0 and pH 7.5 (Figure 4.4).  
We assigned MLDPMT at pH 7.0 to maximize the number of assignable resonances 
in the presence of 150 mM LMPG (Figure 4.6). Linewidths for the MLDPMT in the micelle 
bound state are uniformly 50% greater than that observed in the solution state, 
suggesting a single state that is in fact bound to the micelle. We assigned most of the 
heavy atoms (93.2%) and nearly all of the backbone chain (98.7%) (Figure 4.5, left 
panel). Most of the missing side-chain heavy atoms were either CD/CE residues in R, K, 
and I residues or next to the two Ps; the missing amide came from residue I20, which 
appears to be in a hinge region between loop H1 and loop L1 and thus could be 
participating in either amide exchange or loop dynamics.  
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TALOS+ analysis (Figure 4.5, right panel) showed that secondary structure changes 
occur around loops L1, L2, and L3. As discussed in greater detail in chapter 3.3.1, in 
loop L1, the 9-residue loop L1 observed in the solution structure appears only as a 3 
residue loop L1 upon binding to micelles (residues GKP). The 3 residue loop L1 would 
be consistent with a hairpin loop or an extended conformation. Loop L3 also appears to 
be reduced to 2 residues while loop L2 has a significant reduction in the variation 
predicted in the phi and psi angles. These data are in support of a conformation change 
as elaborated upon in the discussion below. 
	  	  
Figure 4.5:  Micelle assignments and TALOS+ dihedral angles of micelle state. (Left) 
1H -15N 2D HSQC spectrum of MLDPMT bound to LMPG micelles (150 mM LMPG: 1 mM 
MLDPMT) acquired at 600 MHz (1H frequency) at pH 7.0. Of the 77 expected core amide 
resonances, 76 are observed and assigned. (Right) Secondary structure elements of 
the micelle bound MLDPMT identified by TALOS+ compared to the TALOS+ results from 
the solution NMR structure of the MLDPMT.33 Plotted are the Phi (Φ) (black circles) and 
Psi (Ψ) (gray squares) backbone torsion angles as predicted by TALOS+.33 Along the 
x-axis is a cartoon representation of the secondary structure based on the solution 
NMR structure [Solution (blue)] and the secondary structure predicted by TALOS+ for 
the micelle bound state (light blue). The residue numbers from the construct for the 
solution and micelle spectra of PMT (in parenthesis) are both listed along the x-axis. 	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Figure 4.6.  15N-HSQC Spectra as a function of LMPG concentration and pH.  Higher 
concentrations of LMPG and cytosolic pH (7.0 and 7.5) appear to give the most well-
resolved spectra. 
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Key histidine salt-bridges explain the chemical shift perturbation map and dynamics. 
From the solution structure of MLDPMT solved using NOEs and dihedral angles, we can 
add in additional restraints to create inter-helical salt-bridges without introducing any 
violations (Figure 4.8). The conformation of loop L2 appears to be held in place by 5 
salt-bridges between helices H1 and H4 (A) and helices H3 and H2 (B), including one 
salt bridge just next to loop L2 (residues R33-E42).  
 Between helices H3 and H4 we observe a significant network (H48-E78, D55-R71, 
E58-R66) of putative salt-bridges, including between residues R66 and E58, which also 
exhibit elevated R1ρ and R2ρ exchange rates (Figure 4.4B). The salt bridge formed by 
H48-E78 is solvent exposed, which likely explains the higher sensitivity of its chemical 
shift to pH compared to that of residue H35. In contrast, there is only one salt bridge 
(H35-E7) between helices H1 and H2. This H35-E7 salt-bridge is consistent with the 
following NOEs: V3HB-H35HE1, P6HD-H35HD2, L31HG-H35HD2, P6HB-H35HD2, 
P6HG-H35HD2, H35HD2-E7HG. We observe reduced dynamics in loop L1 compared 
to loop L3, suggesting that this salt-bridge is present at both endosomal and cytosolic 
pH.  
 
Liposome pulldown assay of MLDPMT reveals binding to anionic phospholipids at both 
cytosolic and endosomal pH. The putative intoxication pathway of PMT exposes the 
MLD to multiple pHs, as PMT progresses upon endocytosis through the endosomal 
pathway. It is believed that a pH triggered pore is formed in the late endosome (~pH 
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6.0).26 Thus, we decided to look at how pH affected liposome binding and to verify the 
specificity to negatively charged phospholipids using a pulldown assay, similar to what 
has been done for other MLDs previously.2 
 Since we know from a previous mutagenesis study that electrostatic interactions 
play a key role in at least the initial step in membrane binding2, decreasing the pH, and 
thus increasing the overall positive charge on the protein, should enhance binding to the 
negatively charged liposome. With the PC/PE liposome (Figure 4.7A), MLDPMT showed 
only background levels of binding (~10%, Figure 4.7C) across all pHs. In the case of the 
PC/PG/PE liposome (Figure 4.7B), binding ranged from ~37.5% (pH 7.5) to ~75% (pH 
6.0) (Figure 4.7C). Cleavage of the His6-tag significantly reduces observed binding in 
this assay at 50 mM KCl (Figure 4.7D), and thus suggests a more transient interaction 
with anionic phospholipids that can be stabilized by the presence of the additional 
charges in the His6-tag. As further explained in chapter 5.2, we believe that part of the 
C2 domain may in fact be responsible for increasing the affinity to the membrane either 
through binding to the anionic phospholipid or a protein co-receptor. The His6-tag would 
serve the purpose of this secondary binding site in the absence of the C2 domain, 
increasing the affinity to the anionic phospholipids, which is still observed in the 
absence of the His6-tag at pH 7.5, just with additional line-broadening indicative of slow 
exchange on the millisecond time-scale. 
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Figure 4.7.  Liposome pulldown assay of MLDPMT at physiological pH values. 
Liposome pulldown after incubation of MLDPMT with 30% PE/ 20% PC/ 30% PG / 20 
% CHL by mol or 30% PE/ 50% PC/ 20% CHL liposomes at pH 7.5 (cytosolic), pH 
7.0, pH 6.5, and pH 6.0 (endosomal) shows that the binding of MLDPMT is 
significantly greater to the anionic PC/PG/PE liposome at all pHs. 3µM MLDs were 
incubated with 3 mM lipid formed into vesicles (see methods) by extrusion at 37°C 
for 5 min and the mixtures were ultracentrifuged at ~170,000 rcf for 1 hour at 4°C in a 
SLA-100 rotor to determine lipid binding. Background levels of binding were 
observed to PC/PE liposomes at about 10% (A). We observed a significant increase 
in binding to anionic phospholipids between pH 6.0 and pH 7.5 (B) from 37.5% to 
80.0% (C). Removal of His6-tag eliminated binding during LPD assay, suggesting a 
significant contribution from the affinity tag to the lipid binding interaction (D). 
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4.6. Discussion 
 In this study, we found that the MLD from PMT forms a stable 4HB in the solution 
state. However, the conformation and dynamics associated with the 4HB are sensitive 
to pH. Also, the secondary structure is sensitive to the presence of a lipid environment, 
as observed in the TALOS+ angles for the micelle-bound state. The results from our 
study indicate that there is a pH-sensitive salt-bridge between residues H48 and E78 
that may alter loop L3 dynamics in the endosome (pH 6.0) versus in the cytosol (pH 
7.5), as shown in T1ρ, T2ρ (Figure 4.4), R2, and Kex measurements (Figure 4.10). 
Microsecond-scale dynamics appear important for proper binding as supported by 
single conformations (Figure 4.4) only being observed in the LMPG micelle bound state 
at pH 7.0 and pH 7.5. This is in contrast to the solution-state, where the chemical shift 
changes between pH 6.0 and pH 7.5 could easily be tracked; the pH change did not 
cause a change in either the linewidths or the quality of the spectra. 
 Perturbation mapping of the aromatic H protons and side-chain carbonyls suggest 
that only residue H48 and not residue H35 is titratable. In conjunction with the increased 
amide perturbations surrounding residue H48, this suggests that the switching of a 
protonated H48 to a deprotonation of residue H48 results in the loss of the H48-E78 
salt-bridge. The protonation state of H48 and the ability to form the H48-E78 salt bridge 
attributes to the observed pH dependent dynamics in loop L3 that may be important for 
binding. Confirming the role of this salt bridge will require mutagenesis studies.  
 While this new proposed mechanism does not refute the hypothesis that loop L1 
contains key electrostatic interactions to promote binding, it suggests that the 4HB is not 
the only conformation observed upon binding to the membrane and the 4HB could 
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adopting a secondary state that is dependent upon loop L3 dynamics; these dynamics 
may relate to the observation of a single, averaged conformation upon interacting with 
anionic membranes in the construct containing the His6-tag.  
 Further analysis of the TALOS+ chemical shifts indicates that the long loop L1 is 
truncated into either a hairpin loop or it adopts an extended conformation analogous to 
that observed in the crystal structure 4ERR. Significant perturbations observed within 
the phi/psi angles of loops L2 and L3 are also indicative of a significant conformation 
change upon binding that appears to be more indicative of loops L2 and L3 acting as 
hinge regions versus a simple insertion or binding of the 4HB. 
 The transient nature of the MLD interactions is supported by a broadening of the 
linewidth by ~33% in the nitrogen dimension upon removal of the His6-tag at pH 7.5, 
while the spectrum at pH 6.0 without the His6-tag becomes well resolved without a 
subsequent increase in linewidth in either the proton or nitrogen dimension. This 
supports our hypothesis that while the MLD might interact with the lipid at pH 6.0 that 
the more physiologically relevant interaction occurs between the MLD and the anionic 
phospholipid at cytosolic pH as an on/off type interaction. We believe this mechanism is 
necessary for optimal targeting of the PMT-C3 effector domain to G-proteins located at 
the plasma membrane. This type of transient interaction would account for the inability 
to pulldown the MLD using liposomes once the His6-tag is cleaved, as the positive 
charge on the His6-tag tag would supply an additional mode of binding that apparently 
reduces the disassociation constant from the mM range to the µM range; however, at 
this time there is no direct measurement of the the mM binding affinity in the absence of 
this His6-tag and therefore further study is required to clarify this issue. Determining the 
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exact affinity and the role loop residues play in the affinity of MLDs to liposomes is a 
future direction that is outside the scope of this study, but is discussed in detail in 
chapter 5.2. 
 
 
  
 
 
 
 
  
 
Figure 4.8.  Based on the NOEs and the structure, we have found multiple salt-
bridges that we believe hold the 4HB together and make it tight at low pH 
including two histidine salt-bridges. The residues are color-coded (legend bottom 
right). (A) Between helices H1 and H4: residues R12 and E72. Between loops L1 
and L3: residues K18 and E65. (B) Between helices H2 and H3: residues R26 
and E52, K30 and E49, R33 and E42. (C) Between helices H3 and H4: residues 
H48 and E78, D55 and R71, E58 and R66. (D) Between helices H1 and H2: 
residues H35 and E7. The chemical shift of the aromatic residue H35 does not 
change as a function of pH (SIFigure 2). (E) We believe it is due to the stability of 
a T5-E7-H35 salt-bridge complex where residue T5 stabilizes the orientation of 
residue E7 to form a salt bridge with the NE from residue H35. 
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Figure 4.9.  Solution-state NMR determination of amide peak intensity as a 
function of pH for MLDPMT. Heat map demonstrating intensity changes as a 
function of pH by residue normalized to residue I39.  Similar results are 
observed normalizing for residues W4 or L82, whose amide chemical shifts do 
not change significantly in position or in intensity.  The highest intensity losses 
are observed in loops L1, L2, and L3, suggesting either dynamics or amide-
exchange.  An increase in intensity is observed for residues H35, H48, and the 
residues surrounding them.  This is mapped onto the lowest energy NMR 
structure from XPLOR-NIH (bottom left) and color-coded with intensity changes 
from pH 6.0 to pH 8.0, with intensity loss indicated by blue and intensity gain is 
indicated by red.  Intensity loss is mainly observed in loops L1, L3, and to a 
lesser extent in loop L2 (bottom right). 
. 
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 At pH 6.0, the high-resolution NMR structure supports the observation that a 
significant network of salt-bridges are in place to hold together the 4HB as it passes 
through the endosome, including two His salt-bridges. Residue H48 is conserved in 16 
of the 24 putative MLDs; residue H35 is conserved in 17 of the 24 MLDs; and 10 of 
those 17 also contain a AxxB or AxB motif where A is either Thr or Ser and B is either 
Glu or Asp. This latter motif is what we believe is important for the non-titratable state of 
residue H35 and thus the formation of its salt-bridge and the corresponding lack of 
perturbations surrounding residue H35 when compared to residue H48. Threonines are 
known in viruses to be important for orienting glutamates for a key salt bridge in the 
capsids for lentiviruses, which also process through the endosomal pathway.27 While 
the MARTX toxins do not proceed through the endosomal pathway28 and thus do not 
undergo acidification, they still contain this putative motif; this suggests that this motif 
may be selected for even for toxins that do not progress through the endosome to 
stabilize helices H1 and H2 since there are no other electrostatic interactions stabilizing 
the proximal relationship between helices H1 and H2.  
 Taken these observations together, we propose that loop L3 acts as a hinge region, 
where the modification of L3 to an extended conformation results in exposure of the 
hydrophobic core. This model is supported by the amphipathicity of all four helices, as 
calculated according to the hydrophobic moment of > 0.35 and hydrophobicity of < 0.15 
for all four helices of the MLD according to HELIQUEST.29,30 The model is also 
consistent with the crystal structure of the homologous MLDVvDUF5 where we observe a 
hydrophobic interface in the dimer structure of 4ERR. We hypothesize that this 
hydrophobic interface could be the hydrophobic anchors for MLD binding and insertion 
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into the membrane. 
  
  
  
 
 
  
 
  
 
 
 
 
 
  
 
 
 
 
 
  
 
  
 
Figure 4.10.  Dynamics measurements of MLDPMT. Plot of (A) R1, (B) R2, (C) 
NOE, (D) S2, (E) and Kex determined at 30°C by residue show the similarities 
between MLDPMT at both pH 7.5 (blue square) and pH 6.0 (red diamond) 
except in L1 and L3. (A) We observe a slight shift in R1 to a shorter value at 
pH 7.5 compared to pH 6.0 while (B) R2 appears to be slightly longer. (C) This 
results in a corresponding increase in the correlation time. (D) NOE values and 
(E) order parameters appear similar between pH 6.0 and 7.4 indicating no 
gross change in loop and/or helical regions, but we do observe a significant 
increase in the mobility of loop 3 according to (B) R2 and (F) Kex at pH 7.5, and 
to a lesser extent in L1. 
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 The concept of a secondary conformation is further supported by the pattern of 
observed amide intensities as a function of pH (Figure 4.9). Normally we would expect 
to observe relatively weaker amide intensities at pH 7.4 for all residues that are not (1) 
contained within a hydrophobic pocket, (2) in a helix (excepting for the first 3 residues), 
or (3) in some other hydrogen bonding network.31 What we instead observe is that the 
the intensity as a function of pH changes the least for residues W4 to A13, indicative of 
an extended helical conformation or some sort of rigid conformation in the non-helical 
residues of W4, T5, and V8. Loop L3, as we would expect in a dynamic state, has 
reduced signal intensities (consistent with elevated amide exchange rates as the most 
likely explanation) in the helical residues surrounding it, including in residue E58, which 
is likely to be forming a salt-bridge with residue R66. This provides further evidence 
towards our working model of conformational selection including in the dynamics of loop 
L3 being pH dependent due to salt-bridges. Thus, loop L3 dynamics appear to be 
sufficient for single conformation binding only at cytosolic pH, which supports that the 
MLD is not part of the translocation process, but instead is part of the membrane 
targeting process for the catalytic C3 domain from PMT as originally suggested.  
 Therefore, this study provides an intensive investigation of the solution-state MLDPMT 
while providing the backbone assignments and secondary structure of the micelle state. 
The results here provide the platform upon which future studies of the structure and/or 
dynamics of the micelle or liposome bound state can be undertaken to solve the 
structure of the micelle bound MLDPMT. The work presented in this chapter along with 
future studies will enable us to understand the key role that the inherent dynamics of 
MLDPMT in loops L1, L2, and L3 that we identified in this study play in the intoxication 
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pathway for PMT. 
 
4.7. Future Experiments 
 There is substantial difficulty in confirming a crucial hydrogen bond and the role it 
would play on membrane localization.  While we have presented significant 
circumstantial evidence suggesting its existence, mutational analysis is necessary to 
confirm the necessity of these hydrogen bonds. 
 Under our current model, if hydrogen bonds are truly forming between the helices 
based on the protonation state of His residues, then the microsecond dynamics 
determined by T1ρ and T2ρ experiments should also increase at pH 6.0 to levels 
observed at pH 7.5 upon elimination of the His-Glu hydrogen bond by mutation of either 
the His or the Glu. We propose measuring the dynamics at pH 6.0 and pH 7.5 after the 
following mutations: E7N and E78N. These mutations would maintain the overall steric 
structure, but would remove the hydrogen bond acceptor that would be necessary for 
forming the two salt-bridges. If our hypothesis is correct, we should observe significant 
exchange dynamics and/or insolubility analogous to what is observed for MLDVvDUF5 at 
salt concentrations of 100 mM due to formation of dimers or oligomers (discussed in 
greater detail in chapter 5.3.2). 
 We also need to further address the role of the His6-tag, which we discuss in detail 
in chapter 5.2, as it has been observed to significantly increase the affinity of MLDs to 
anionic phospholipids. Finally, if we are suggesting a second conformation, then 
observing and quantifying the lipid to protein distance would provide the topology upon 
micelle binding.  This could potentially be observed through preparation of a U-15N-2D-
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MLDPMT sample at pH 7.0 in the presence of 150 mM LMPG, where a lipid-amide proton 
NOE experiment would be performed32 to determine whether the entire MLD is on the 
surface in an extended conformation, or whether the 4HB is maintained. For the 
extended conformation, we would expect the NOE intensity from the amide to the lipid 
to only depend on its position in the amphipathic helix; i.e. its position in the 3.4 
residues that constitute an alpha helix.  If it remains a 4HB, we would expect the 
intensity to vary significantly depending on its position in the 4HB, as a 4HB cannot 
have all of its residues in simultaneous contact with the membrane. Alternatively, lipid-
appended stable radicals (e.g., doxyl-PC) could be utilized for paramagnetic relaxation 
measurements to the protein, and a similar pattern of paramagnetic relaxation effects 
would be expected.  
 While this would not solve the structure, it would provide the answer to the 
fundamental question as to whether or not the 4HB is maintained upon interacting with 
LMPG. These proposed experiments should answer the remaining questions with 
regards to this story, and help to further our understanding of the mechanism by which 
MLDs interact with membranes. 
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CHAPTER	  5	  
Conclusions	  and	  Future	  Directions	  
5.1. Discussion of Key Findings 
 As discussed in chapter 1, this thesis was an investigation into how domains from 
biotoxins interact with membranes using biophysical and structural studies. We have 
attempted to understand how PMT and toxins with homologous domains interact with 
membranes at the endocytosis step, translocation step, and/or membrane-targeting 
step during intoxication using in vitro studies. In the following discussion, we place the 
studies from this thesis in context with other unpublished work and propose future 
directions to broaden the implications and significance of this research project.  
In chapter 2, we used TLC-overlay, SPR, and liposome pulldown assays to show 
that PMT has a preference in binding to the zwitterionic sphingomyelin (Figure 5.1). 
Removal of the sphingomyelin head-group to form ceramide caused a 3-fold decrease 
in the slow on-rate kinetics, which is consistent with TLC-overlay studies showing that 
PMT-N and PMT show some affinity to ceramides and PC, but none to any of the 
anionic phospholipids or glycans. However, PMT-C does bind to PS, which is consistent 
with other published observations using liposome pulldown assays as discussed in 
detail in chapters 1, 3 and 4.1  
In chapter 3, we assigned the solution and micelle bound states of the MLDPMT, as 
well as the MLD from the homologous domain of the MARTX toxin from V. vulnificus 
adjacent to the DUF5 domain (Figure 5.1). This revealed the expected 4HB in the 
solution state. However, we observed a potential change to an extended conformation 
in the micelle bound state, as the predicted secondary structure from TALOS+.  An 
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extended MLDVvDUF5 dimer conformation is observed in a crystal structure (PDB 4ERR). 
Dynamics measurements and perturbation mapping in chapter 4 suggest that for 
MLDPMT that a similar conformational change could occur. In short, the loop L3 
conformation and dynamics depend upon the protonation state of residue H48, and this 
event is potentially key to membrane binding and the ability to adopt an extended 
conformation, as suggested by the similarity of the TALOS+ phi and psi angles in loop 
L3 (Figure 5.2).   
 
 
 	  
Figure 5.1:  Proposed intoxication 
pathway of PMT highlighting details of 
toxin-membrane interactions revealed 
through these studies. From our initial 
model of the intoxication of PMT, we 
have filled in the following parts (see red 
boxes). We have identified SM as a co-
receptor for binding that we believe is 
required for endocytosis (Chapter 2) and 
we have identified a novel mechanism 
for binding of the MLDPMT that requires 
L3 dynamics that we believe causes 
selection for an extended conformation 
(Chapters 3 and 4). This would generate 
a structure analogous to that observed in 
the crystal structure of MLDVvDUF5, PDB:  
4ERR. Further work is going to be 
necessary to determine the protein co-
receptor needed for endocytosis, the 
structure, state, and mechanism of 
translocation, and the lipid-bound state 
conformation and dynamics of MLDPMT. 	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5.2. The Physiological Role of the MLD in Intoxication 
The role of the MLD in targeting effector domains to the plasma membrane in tissue 
cultures has only been revealed recently, but the precise role the MLD plays in the 
intoxication pathway in vivo is still unknown. Liposome pulldown assays have shown 
that removal of the His6-tag reduces binding affinity to the point it can no longer be co-
precipitated using liposome pulldown assays (Figure 4.7). This is in contrast to 
transfection data presented in multiple other publications1,10,18, where a non-His6 tagged 
MLD construct from various toxins is attached to GFP in a transfection construct, is 
transfected, and expressed; in these experiments, the MLD-GFP construct is localized 
at the membrane.  However, there are multiple possible explanations for these 
observations. First, concentrations of proteins expressed through transfection have 
been shown to be up to 20% of the total proteins in the cell; a very high local 
concentration could alter the dimer-to-monomer ratio of protein, induce formation of 
larger oligomers or aggregates, and/or shift the binding equilibrium to favor membrane 
association.19 Second, the MLD may have preferential binding to a protein or other 
specific non-protein receptor in vivo with high affinity. Therefore, we need to find the 
physiologically relevant role of the MLD during intoxication in vivo. 
 Another hypothesis is that there is a secondary binding site within the effector 
domain that helps increase the affinity to the membrane inner leaflet. Transfection of 
sub-domains of PMT and the effect on the serum response has revealed that the C3 
domain alone maintains activity for PMT20, but transfection of the C1-C2-C3 domain has 
over 2-fold greater activity. However, transfection of C2-C3 has less than half of the 
activity observed during transfection of C3 alone, which infers either that the C2-C3 
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domain complex is unstable, or that the C2 domain only assists in intoxication in 
conjunction with the C1 domain. There is currently no known function of the putative 
C2a (residues 719-840) or C2b domains (residues 840-1103), and thus it is possible 
that an additional membrane targeting domain is embedded within this domain.   
 While no work has verified this hypothesis that the effector domains next to the 
MLDs have a secondary binding site, the three types of domains flanked by MLDs (90 
residues, 10 kDa) are all 400-450 residues in size (~50kDa). Cleavage of the His6-tag 
has shown that the MLD by itself has a significantly reduced affinity for anionic 
membranes, so it is possible that these effector domains would contain a secondary 
binding site to provide a multi-prong binding with a protein and/or a lipid/glycan co-
receptor complex.  This has already been proposed for the N-terminus of PMT as 
discussed in chapter 2 for extracellular membrane binding and has been observed in 
BoNT as well for extracellular receptor binding.   
 A synergistic binding effect to properly target the C3 effector domain to G-
proteins would explain why removal of the MLD itself eliminates catalytic activity, but yet 
the C3 domain alone retains activity. Additional transfection assays where the MLD is 
directly spliced with the C3 domain and compared to the C3 domain, as well as the C1-
C2-C3 domain would enable us to understand whether the MLD actually enhances 
intoxication without the presence of the C2 domain. 
 A quantitative determination of the kinetic and thermodynamic binding affinity using 
isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), and liposome 
pulldown assays assaying higher concentrations of MLDs with and without the His6-tag 
would enable us to determine whether the affinity of the MLD to anionic phospholipids 
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alone is sufficient to target the effector domain(s) to the membrane and thus increase 
toxicity in vivo. The comparison of these values across MLDs may help to explain the 
differences in MLD amino acid sequence despite the sequence similarity and identity 
observed.1  
5.3.  Discussion of Structure-Function Relationship in MLDs 
5.3.1.  Sequence Analysis of Loops L1 and L3 in MLDPMT and MLDVvDUF5 
Despite likely homology predicted by the observed significant sequence identity 
between MLDPMT and MLDVvDUF5 (37% residue identities, 54% residue similarity), we 
have observed subtle differences even within the secondary structure of the micelle-
bound state that may impact binding and perhaps relate to their functionality in 
virulence. The novel mechanism discussed in chapter 4 contrasts with the original 
hypothesis that the MLD was simply being anchored in the membrane by loops L1 and 
L3 through a combination of electrostatic interactions and hydrophobic insertion. 
Evidence presented here suggests that the residues in loops L1 and L3 influence the 
observed dynamics and subsequently the equilibrium between the solution-state 
conformer and the micelle-bound conformer (Figure 1.2). This is supported by a more 
in-depth analysis of the sequences of MLDPMT and MLDVvDUF5. 
Between loops L1 and L3 in MLDPMT and MLDVvDUF5, we observe a 62% identity and 
a 69% similarity; this is maintained even when including the two residues on either edge 
of the loop. In contrast, residues outside of loops L1 and L3 share only 28% identity. 
The role of the loop L1 region in membrane binding is supported by mutational studies 
performed in the Satchell Lab that show that mutation of key lysines or phenylalanine 
residues in loop L1 of MLDVvDUF5 caused a significant decrease in membrane binding.1 It 
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was hypothesized that while the Lys to Ala mutation would decrease the electrostatic 
interactions, the F17N mutation in MLDVvDUF5 mutated a key hydrophobic residue. 
Results reported herein suggest that instead it might interfere with helix elongation in 
loop L1. We believe this might be the case, as mutation of F to an N would decrease the 
propensity of residues to form a helix according to the list of residue propensities in the 
Biological Magnetic Resonance Bank (BMRB). [ref] 
Using the same information from the BMRB, the residues that would be expected to 
be helical breakers (Lys, Pro, Ile, Gly) exist both in MLDVvDUF5 and in MLDPMT. However 
it appears that the difference in the observed loop L1 geometries is due to the X 
residue, which in MLDPMT is a Gly, a helix-breaking residue and in MLDVvDUF5 is an Ala, 
a helix-forming residue. This would result in significantly different loop L1 geometries as 
shown (Figure 5.2). What is of note is that in the case of MLDPMT that the long loop L1 in 
solution (Figure 5.2A) might turn into a hairpin loop upon interacting and binding to 
anionic phospholipid membranes (Figure 5.2B), which would be consistent with 
observations in chapter 4 about a chemically inert salt-bridge. The geometry of the 
residues in loop L1 for MLDVvDUF5 in contrast converges to form what appears to be an 
extended helix, consistent with the crystal structure from 4ERR (Figure 5.2C and D). 
Initial CPMG experiments on the wild-type MLDVvDUF5 suggest significant exchange 
dynamics in loop L1 for MLDVvDUF5 in comparison to MLDPMT. This might suggest that 
loop L1 in MLDPMT may be a hairpin turn, while in MLDVvDUF5 loop L1 is in an extended 
conformation as shown via TALOS+ angles in the micelle state (Figure 5.2) and the 
crystal structure of the extended dimeric state. What is interesting is that the TALOS+ 
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angles for loop L3 in MLDPMT and MLDVvDUF5 suggest similar angles and thus a similar 
conformation of L3 upon micelle binding for both MLDs. 
Further study of the exchange dynamics in loops L1 and L3 for the micelle-bound 
state may improve our understanding of the mechanism of binding, once interpreted in 
the context of the micelle-bound structure. In particular, using the adiabatic pulse 
scheme described in chapter 4 to interrogate fast ms/slow µs interactions (as measured 
by T1ρ and T2ρ) would likely help reveal and/or confirm any key dynamics that we 
predict are essential for membrane binding. We believe this may serve as a way to 
understand why the F17N mutant does not share the same affinity to anionic lipids 
according to the liposome pulldown assay, and can be further tested through measuring 
both binding and dynamics for the A18G mutant. Through these studies, we will be able 
to determine the structure-function relationship of loop residues within MLDPMT and 
MLDVvDUF5, which should also help us to understand the patterns of amide peak 
intensities discussed below. 
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Figure 5.2:  Comparison of the dihedral angles in loops L1 and L3 for MLDPMT 
and MLDVvDUF5. As discussed in chapter 3, loop L1 has a significant change in 
conformation that leads to loop L1 transforming into a helix (A and C) or 
truncation of loop L1 (B and D). We also see a slight shift in phi and psi angles in 
loop L3 as well. Comparison of loop L3 in MLDVvDUF5 and MLDPMT reveal highly 
similar loop geometries. 	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5.3.2. Amide peak intensity patterns and size-exclusion chromatography of 
MLDs suggest differences in MLD structure and dynamics between MLDPMT 
and MLDVvDUF5 
 
While chapter 4 briefly discussed the implications of the intensity losses observed 
upon titration of MLDPMT from 6.0 to 7.5 and what the amide peak intensities suggest 
about the structure as a function of pH, greater analysis may infer some more nuanced 
structural details. We would expect that those amides observed, which are consistent 
with a slower exchange rate, either exist within a hydrophobic pocket absent of water, or 
are involved as hydrogen donors in a hydrogen-bonding network, such as in α-helices. 
At pH 7.5, we would expect the other solution-exposed residues to be in fast-exchange, 
primarily those at the beginning of helices (hydrogen bond acceptors only) and those 
within loop regions; this would be observed by a significant loss in intensity compared to 
pH 6.0.2 This is generally the case with few exceptions for MLDPMT, most importantly for 
residues W4, T5, E7, and V8, implying that this loop region is less solvent-exposed and 
is likely more rigid, as would be the case for the putative E7-H35 salt-bridge discussed 
in chapter 4. 
We notice that for MLDVvDUF5, loop L3 has multiple residues that have significant loss 
in amide intensity while only residue F17 in loop L1 and residue R41 in loop L2 are not 
observed; in contrast we observe less than 20 percent intensity for MLDPMT at pH 7.5 for 
residues V15, G17, I20, E22, and S23 in loop L1 and for residues N38 and L40 for loop 
L2. In addition to the residues in loop L3 that are missing in both MLDPMT and 
MLDVvDUF5, we also observe the latter parts of helix H3, including residue S60, has 
significantly reduced intensities. In the model of a simple 4HB at pH 7.5, we would 
expect that the loop residues and the first 3-4 residues in each of the helices would be 
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weak or unassignable. Since this is not the case and since the two MLDs show different 
patterns of amide peak intensities, other interactions between amides in loop regions 
may be at play and that the structure and dynamics need to be explored further for 
MLDVvDUF5 to understand why the observed amide exchange rate is reduced for 
residues surrounding loops L1 and L2. This may be explained by a second 
conformation that is the extended state that is observed upon micelle binding, as 
explained in chapter 3.5.  
 
A potential structure-function relationship becomes apparent when one looks at the 
potential salt-bridges for MLDVvDUF5; the acidic residues are for the most part either 
sequentially next to a basic residue, or that they are on the same face of the helix (I +/- 
3 or 4). The lack of stabilizing salt-bridges in MLDVvDUF5 is consistent with the 
	  
Figure 5.3:  Preliminary solution NMR structure of MLDVvDUF5. The initial structure of 
MLDVvDUF5 solved using the PASD algorithm from XPLOR-NIH and manual 
assignment, including dihedral angles and J-coupling values. Acidic residues (blue) 
are observed sequentially or on the same helical face as basic residues (red) in 
contrast to the salt-bridges observed in MLDPMT 
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observation that the protein exists as an equilibrium mixture of monomer and dimer at 
low temperature (using size-exclusion chromatography using a Sephacryl S-100 column 
at 4°C), but the equilibrium shifts to favor the monomer after incubation at 37°C for 30 
minutes (Figure 5.4). Thus it appears that the initial low temperature population is a 
metastable equilibrium state, and that once the conversion back to monomer is 
activated at higher temperature, the monomer is stable for days to weeks. The 
hypothesis that the dimer spontaneously reverts back to monomer at higher 
temperature is supported by acquiring and comparing the HSQC and PFG-Diffusion 
spectra of the monomer and dimer at 30°C a pH 7.4 in 500 mM NaCl, as explained in 
detail in chapter 3.4. In contrast, MLDPMT only purifies as a monomer (Figure 5.4) at 4°C 
at pH 7.4 in 500 mM NaCl.  
We believe that there are no inter-helical salt-bridges (Figure 5.3), including the key 
His salt-bridges observed in MLDPMT. The concept of salt bridges being selected for in 
MLDPMT makes sense evolutionarily since MLDVvDUF5 enters the cell at cytosolic pH 
without experiencing endosomal pH; i.e., that there is no selective pressure to have salt-
bridges that stabilize the 4HB when the toxin is immediately entering the cell and 
delivering its effector domain to the membrane surface upon being released from the 
toxin via IP6-dependent CPD domain cleavage of the linker region.3  
 The observation that MLDPMT purifies as a monomer and not as a monomer/dimer 
mixture like MLDVvDUF5, likely due to the existence of an extensive salt-bridge network in 
MLDPMT, supports that MLDs likely do have non-interchangeable loops and helices, 
where the loop residues for each MLD have been selected for optimized dynamics that 
will maximize effector domain targeting and subsequent intoxication. While less 
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evidence of conservation is observed in the helices, we believe that key salt-bridges 
that can help stabilize the dynamics for toxins are selected for only in toxins that need to 
be endocytosed. This requires a more robust study that is discussed below in chapter 
5.3. 
 
	  
Figure 5.4:  Sephacryl S-100 FPLC traces of MLDPMT (TOP), MLDVvDUF (MIDDLE), 
and MLDVvDUF5 dimer peak (BOTTOM) after concentration, incubation at 37°C, and 
re-running on Sephacryl S-100 column.  As can be observed, while MLDPMT is 
observed as a single peak corresponding to monomer, MLDVvDUF5 forms a reversible 
dimer.   
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5.3.3. Current Directions for Understanding Loop Dynamics and Their Role in 
Membrane Binding 
 
The next set of experiments needed to further understand the topology of MLD 
structures in the solution-state, in the micelle bound-state, and in the liposome bound-
state are challenging. We have solved the high-resolution structure of MLDPMT (chapter 
4) and initial structure calculations for MLDVvDUF5 (Figure 5.3) reveal the expected 4HB 
structure.  
Solving the micelle-bound structure requires additional samples and experiments. 
For example, deuteration of the lipids is necessary to acquire NOESY spectra without 
lipid protons compromising sensitivity through spin diffusion pathways. Additional 
restraints from residual dipolar couplings will likely be needed to define the helix 
orientations accurately, since NOE restraints are not sufficiently long-range and/or 
precise for this purpose.  Lipid-to-protein amide NOE experiments are one route to 
explore the protein-micelle interface; paramagnetic relaxation measurements provide 
another route. 
To fully understand the insertion of the MLD into a native bilayer with surface 
curvature similar to that found in the inner leaflet of the cell, SSNMR samples have 
been prepared (Figure 3.1) and are in the process of being assigned using standard 
labeling patterns (uniformly carbon labeled samples, and 1,3 or 2-glycerol labeled 
samples). This will allow for site-specific determination of membrane insertion and a 
complete understanding of the topology. These projects will be continued in the future, 
but the steps we have taken in this thesis towards assignments of the liposome bound 
MLDVvDUF5 are discussed below. 
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5.4: Initial Solid-State NMR Studies 
 While solution NMR has many advantages over SSNMR with regards to ease of use 
and sensitivity, as elaborated in chapter 1, it is important to study the MLDs in a more 
physiologically relevant membrane with less curvature, which can only be done using 
SSNMR. Preparation of SSNMR samples will allow us to investigate the topology of 
insertion into the native membrane using spin-diffusion, REDOR, and PRE experiments. 
 Initial spectra using SSNMR have shown that we can obtain reasonable 2D spectra 
for both MLDPMT and MLDVvDUF5. Our initial samples used sub-optimal purification 
techniques, as they lacked the size-exclusion chromatography step that eliminated high 
molecular weight impurities that co-purified through the nickel column, were incubated 
with liposomes that were generated via sonication, and thus not uniform and likely 
contained micelles, and were subsequently lyophilized, potentially disrupting the lipid 
bilayer. 
 In detail, the protocol used to make the original SSNMR samples for MLDVvDUF5 from 
a stock solution of MLDVvDUF5 (chapter 3.2.2), including the sample that was used to 
acquire the spectra (Figure 5.5, left panel) was as follows. Liposomes were prepared in 
the following way: 7.5 mg of cholesterol (dry mass) was mixed with 44 mg of 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 10 mg of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphoglycerol (POPG) from powder and suspended in 500 µL of 
50/50 chloroform/methanol. This mixture was then sonicated for 1 minute using a 
Branson Bath 1200 sonicator to promote dissolving of the lipids as well as mixing in a 
polypropylene tube. The lipids were then dried under nitrogen for 30 minutes until a film 
was observed and put under speed vacuum for 1 hour to remove trace solvents.  The 
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lipids were re-suspended to yield ~20 mg/mL in 3 mL of 10 mM tris-HCl, pH 7.4, with 10 
mM NaCl buffer and then flash-frozen followed by sonication using bath sonication until 
the lipid mixture thawed (5x). This was followed by 5 minutes of sonication to produce 
small unilamellar vesicles. This mixture was then diluted to 5 mg/mL lipid in 10 mM tris-
HCl, pH 7.4 buffer, with 10 mM NaCl buffer (12 mL total volume) and split into 2 tubes 
(6 mL in each), followed by addition of 7.5 mg of concentrated MLDVvDUF5 in 20 mM tris-
HCl, pH 7.4 buffer, with 500 mM NaCl (~15 mg/mL) to 30:1 lipid:protein ratio (final salt 
concentration in solution of ~75 mM).  This was incubated at room temperature for 15 
minutes, mixed by pipetting, and incubated for another 15 minutes before being diluted 
to 8 mL by 10 mM tris-HCl, pH 7.4 buffer, with 10 mM NaCl, and subjected to ultra-
centrifugation for 1 hour at 96,000 rcf and 25ºC in a TI-72 rotor. The supernatants were 
then decanted and the pellets were scraped into an Eppendorf tube with perforations in 
the top, flash-frozen, and lyophilized overnight.  The sample was then packed into a 
rotor and re-hydrated by addition of water (1 mg of water for every 2 mg of protein/lipid 
mixture). While we were able to pack ~6 mg of protein into a 24-mg rotor, significant 
heterogeneity was observed within the alanines, as beta-sheet alanines appeared that 
were inconsistent with any hypothetical structure or any conformation observed in the 
solution state according to TALOS+ (Figure 5.5, left).  
 To generate better homogeneity and thus produce better spectra, we both optimized 
protein purification by adding a size exclusion step during protein purification that is 
discussed in detail in chapter 3.4.2, improved the uniformity of the liposomes, and 
eliminated the lyophilization step to ensure uniformity of the lipid bilayer. The sample 
used to acquire the spectra observed in the right panel of Figure 5.5 was prepared as 
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follows. Liposomes were prepared used the following lipid composition: 47 mg POPC:47 
mg POPG: 6 mg CHL (4.5:4.5:1 molar ratio), with the lipids coming from chloroform 
stocks from Avanti Polar Lipids. After drying with nitrogen gas, the lipids were re-
suspended in 5 mL of cyclohexane, sealed using a teflon cap with 2 holes in the top 
where syringe needles were inserted, flash-frozen using liquid nitrogen, and lyophilized 
overnight. The lipids appeared as a white, fluffy powder the next day. These lipids were 
re-suspended in 5 mL of 10 mM tris, pH 7.4 buffer with 10 mM NaCl and 0.01% sodium 
azide (w/v). After resuspension, the lipid solution was flash frozen and subsequently 
thawed 5 times, using liquid nitrogen to freeze the lipid mixture and thawing under 
running water. This freeze-thaw process generates multi-lamellar vesicles. These 
vesicles were then extruded using the Avanti Polar Lipids Extruder 11 times, through 
first a 1.0 µm membrane followed by a 0.2 µm membrane and then finally a 0.05 µm 
membrane. To remove any micelles, the lipids were then added onto a poured ~50 mL 
Sephadex-G50 column pre-equilibrated in 10 mM tris-HCl buffer, pH 7.4, with 10 mM 
NaCl and 0.01% sodium azide (>50 mL of buffer were run through the column post-
packing). The liposomes were loaded before addition of elution buffer (10 mM tris-HCl, 
buffer, pH 7.4 with 10 mM NaCl and 0.01% sodium azide). Successive 2 mL aliquots of 
buffer were added and run through the column using a positive pressure syringe pump 
and collected into 2 mL microfuge tubes in 1-mL aliquots. A total volume of 15 mL of 
buffer was run through the column, and the fractions with the greatest opaqueness were 
pooled. The phospholipid concentration was determined by the ascorbic acid-molybdate 
phosphorus assay. Briefly, the water in the lipid solution was placed into a glass test-
tube and evaporated under nitrogen before addition of 225µL of 8.9 N H2SO4. The 
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sample was then cooked at 200-215°C for 25 min, cooled briefly before adding in 125 
µL of 30% H2O2 and then cooking for an additional 30 min. After removing form the hot-
plate, the sample then had 2.5 mL of 1% ascorbic acid and 0.25% ammonium 
molybdate added before incubation for 5 min at 80°C. The sample was then cooled on 
ice, and the absorbance was taken at 820 nm and compared to phosphorus standards 
(run concurrently). The phosphorous content was then converted into lipid concentration 
(1:1 molar ratio). After determination of the lipid concentration, sterile water was then 
added until the lipids were diluted from ~10-15 mg/mL of liposomes to 10 mg/mL. 
 A 60 mg/mL stock solution of MLDVvDUF5 was diluted down to 10 mg/mL (two aliquots 
of 125 µL of protein with 625 µL of water), centrifuged at 12,000 rcf for 10 min at 4ºC to 
remove aggregates, and then the 750 µL solution was added to two separate 3 mL 
Beckman ultracentrifuge tubes on ice. From here, 300 µL of lipid solution was added 
and mixed via pipette with the protein every 10 minutes until a total volume of 1.5 mL of 
the lipid solution was added. The lipid/protein mixture was then allowed to sit on ice for 
an additional hour before subjecting to ultra-centrifugation. The final volume was 1.5 mL 
of 10 mg/mL lipid to 0.75 mL of 10 mg/mL protein, yielding a 30:1 ratio of lipid to protein 
and a final buffer concentration of ~7.5 mM tris-HCl buffer, pH 7.4, with 35 mM NaCl. 
The samples were then pelleted using a bench-top ultracentrifuge with a TLA-100.3 
rotor for 18+ hours at 200,000 rcf. The supernatant was removed, and the pellet was 
transferred immediately into a rotor, with intermittent centrifugation at 3,220 rcf in a 
spinning bucket rotor to assist in packing the gel-like substance into the rotor.   
 The resulting spectra demonstrated significant increase in spectral signal to noise 
despite the decreased amount of protein in the rotor (Figure 5.5). We also no longer 
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observed beta-sheet alanines that suggest impurities or a heterogeneous sample. The 
extra steps taken in the second protocol appeared to help the sample remain fully 
hydrated and removed high molecular weight impurities, thus reducing formation of non-
specific aggregates that would cause excessive line-broadening and additional peaks. 
 
Carbon correlation spectra have been shown to be useful as a tool to discriminate 
between different models. For example, we previously demonstrated that by 
determining the secondary structure for only a sub-set of residues (VITAL)4 using 
SSNMR, we can rapidly screen homology models that can serve as starting points for 
high-resolution structure calculations. Further advancements in SSNMR will help us to 
	  	  
Figure 5.5:  CC-2D spectra acquired with 20 Hz of line-broadening either for sample 
prepared using the old method with a sample containing 6 mg protein (left) on the 
750WB or using the new method (right) with a sample containing 3.5 mg. Significant 
gains in intensity are observed in the serine and threonine regions in the new sample 
and peaks corresponding to beta-sheet alanines are missing, inferring a more 
homogeneous sample.   	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more quickly understand the protein-liposome interactions and the topology that 
enables the MLD to function.   
 
5.5. Significance and Future Directions of Project 
Anti-virulence strategies are becoming increasingly important with the emergence of 
antibiotic resistant bacteria, which render classical strategies of treating bacterial 
infections less useful. To develop drugs that either block the intoxication pathway or 
manipulate the intoxication pathway to deliver a therapeutic, we must understand the 
mechanism of intoxication, at least at a molecular level. We believe it will be necessary 
to have mechanistic and structural understandings of how each toxin domain interacts 
with the cell and the role it plays in intoxication, which will allow for rational design of 
these new anti-virulence therapeutics. These studies will also result in NMR structures 
of micelle and liposome bound states, which will further our understanding of protein-
membrane structures and interactions. For example, studying the structure and 
dynamics within PMT-N will provide insight into the dermonecrotic toxins from PMT, 
CNF1, and DNT5-7. Studying the structure and dynamics of MLDPMT will also provide 
insight into the intoxication of the other 24 effector domains from 23 different organisms. 
Finally, these studies will provide a rich platform to perform a structure-function analysis 
to understand a new class of protein folds.1 
As with all structural studies, it is ideal to bring the findings back to biological 
relevance. The problem is that in many of the larger toxins that contain MLDs such as 
the MARTX toxins and clostridial toxins, it is difficult to express the full-length toxin in 
recombinant systems due to proteolytic cleavage and/or their large size, making 
isolation and purification of sufficient quantities difficult. Most studies looking at 
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clostridial and MARTX toxins use recombinant toxin fragments that can be readily 
expressed to allow for preparation of large quantities of toxin fragments to then be 
assayed for activity. However, studying toxin fragments in isolation does not allow for a 
complete study of the entire process of intoxication. 
We believe PMT is an ideal platform to test how manipulation of the membrane 
localization domain, including mutation of key residues, will affect downfield toxicity. We 
can readily express tens of milligrams of protein and the proteolytic stability of PMT is 
well documented8,9; this should make the overall construct fairly resilient to point 
mutations allowing us to directly test how a point mutation or domain swap within an 
MLD or other domain impacts toxicity without worrying about compromising the integrity 
of the protein. Intoxication can be measured using established SRE-assays that 
respond directly to the enzymatic activity within the C3 domain of PMT.10  
We believe this multi-pronged approach and iterative feedback loop will give us the 
fullest picture to understand toxin-membrane interactions (Figure 5.6). In short, the 
NMR studies are important for identifying key residues that can be probed via 
mutational analysis as we can site-specifically understand how a mutation impacts not 
only the structure, but the dynamics and membrane interactions of the domain. This will 
be done primarily using the experimental methods discussed in chapter 4. Additional 
SPR methods as explained in chapter 2 can be used to determine the impact on the 
kinetics of binding. Mutations that cause particularly interesting changes in structure 
and/or dynamics would then be used in biological studies to understand how these 
mutations impact intoxication and motivate other mutants that can be interrogated via 
NMR to understand how they impact structure and/or dynamics. 
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This approach can first be optimized on a smaller domain, such as the MLD. From a 
purely structural biology perspective, this domain provides an opportunity to explore and 
examine membrane-associated proteins, which are underrepresented in the PDB.11 This 
will provide another structural motif that can be used for homology modeling of sub-
domains of surface-associated proteins and will enhance our understanding of the 
interactions that are necessary for binding and the topology upon membrane 
association. Due to the many properties described throughout this thesis, the MLD 
provides an ideal case study to continue to advance technologies that are broadly 
applicable to the rest of the structural biology field. 
 
The complete mechanistic understanding of these three membrane interactions: (1) 
binding, (2) translocation, and (3) membrane targeting will enable us to manipulate 
these pathways to deliver therapeutics to specific cellular types as well as to develop 
new anti-virulence drugs that specifically counteract toxin binding and delivery. We 
believe by combining solution and solid-state NMR techniques with toxin biology and 
biophysical assays that we are better able to understand how membrane interactions 
	  
Figure 5.6: Overview of methodologies used for exploration of toxin-membrane 
interactions. This illustrates how we propose to investigate the 4HB to develop a 
complete understanding of how structure and dynamics help with function. Solution 
NMR experiments for the solution and micelle bound states will help accelerate 
SSNMR studies. These will suggest mutations to use for in situ experiments that will 
allow us to understand how these changes that affect structure and dynamics impact 
intoxication and develop a structure-function relationship. 	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play a key role in the intoxication pathway. Future work will enable us to determine how 
toxins have site-specifically evolved these domains to work in conjunction with the entire 
toxin to optimally confer toxicity on targeted cells. While many groups have already 
begun developing diphtheria and botulinum toxin-based protein therapeutic delivery 
mechanisms12-14, cargo design for optimal delivery is still in its infancy. 
The work included in this thesis has made significant strides towards understanding 
toxin-membrane interactions; however, there still remains a substantial amount of work 
to finally characterize the mechanism and structure of many of these translocation 
domains during the translocation process. Currently only membrane pore structures for 
anthrax-toxin and some of the cytolysins have been crystallized and/or modeled using 
cryo-EM15-17, and these methods rely on only a small portion of the protein being 
inserted into the membrane for the entire oligomeric complex. While translocation 
domains alone can be readily expressed and purified as soluble proteins before pore 
formation, allowing for high yield and simple purification before membrane insertion, the 
size of these proteins and complexes have made atomic level studies difficult and serve 
as an important future direction to completely understand intoxication and potential 
therapeutic delivery via AB and MARTX toxins.  
Advances in SSNMR that allow for greater automation of assignment, enhanced 
signal to noise, and labeling schemes that reduce degeneracy will enable us to 
eventually look at these trans-membrane complexes. However, until then the next 
logical step is to look at toxins with small translocation domains such as diphtheria toxin 
to understand the atomic level structure that enables pore-formation. Thus, this thesis is 
the first step towards understanding membrane interactions of PMT and PMT-like 
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domains and lays the groundwork for further research that will enable us to fully 
characterize how these toxin domains interact with membranes. The work in this thesis 
combines solution and solid-state NMR spectroscopy, SPR spectroscopy, as well as 
biochemical assays that enabled us to interrogate the mechanism of toxin-membrane 
interactions and publish multiple papers revealing new information about these 
interactions. We believe that these studies in conjunction with the other aims of the 
project will allow us to understand the membrane interactions of PMT and PMT-like 
domains that interact with membranes that will both provide us with a complete view of 
one mechanism through which bacterial toxin effector domains are delivered into the 
cell while also paving the path for toxin-based therapeutic delivery. 
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